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Abstract
Periplasmic nitrate reductase from Sulfurospirillum barnesii is representative of the
distinct branch of epsilonproteobacteria periplasmic nitrate reductases. The gene
encoding the active subunit of S. barnesii’s periplasmic nitrate reductase (napA) was
successfully cloned into the vector pET101/D/TOPO. Constructs were made both with
and without the sequence coding for the periplasmic signal sequence. Preliminary
expression and purification experiments were performed with limited success. The DNA
encoding the periplasmic signal sequence proved necessary for expression. Even with
the signal sequence coding region, protein expression was limited. The low levels of
expression appeared due to product degradation during cell growth. Purification was
incomplete, with both low recovery levels and significant contamination.
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Introduction

The Nitrogen Cycle
Nitrogen is an essential element for all living organisms. Nitrogen is found in the
environment both as a part of organic molecules (such as protein) and as inorganic
species, primarily nitrate, nitrite, ammonia, and nitric oxide. The inorganic portion of the
global nitrogen cycle is driven primarily by microorganisms, which convert inorganic
nitrogen from one form to another (figure 1).
Human activities can have a significant impact on the nitrogen cycle. Every year,
tons of fixed-nitrogen fertilizers, mostly in the form of ammonia, are applied to
agricultural land. Much of the ammonia applied is quickly transformed to nitrate by
nitrifying bacteria. Since nitrate is susceptible to denitrification (transformation to N2)
and to leaching, the transformation has attracted considerable attention as a source of
fertilizer loss in intensive agricultural systems. The leaching of nitrate into terrestrial and
aquatic ecosystems can lead to environmental problems. Excess nitrogen in the
environment can lead to acidification of soils, eutrophication of water bodies, and, at high
levels, toxicity in plants and animals (5).
Excess nitrate in drinking water can result in methymoglobinemia (blue baby
syndrome). Studies have also linked nitrate consumption to non-hodgekin’s lymphoma,
several forms of cancer, and adverse reproductive outcomes (spontaneous abortions,
stillbirths, premature births, and retarded intrauterine growth). Thyroid hypertrophy,
childhood type I diabetes, and increased blood pressure have also been linked to nitrate
consumption, though further study is needed to confirm these effects (40).
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Figure 1: The inorganic nitrogen cycle. Transformation of inorganic nitrogen from one
species to another is performed primarily by microbes: eukaryotic organisms absorb
nitrogen primarily as nitrate (NO2-) and ammonia (NH4+). Source: Stolz and Basu (31)
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Because of these problems, considerable attention has been given to nitrate
leaching from agricultural systems and the fate of nitrate in the environment. Models
have been developed to explore nitrate leaching (20), and nitrate concentration in
groundwater, both at local and national scales (25). These models consider microbial
denitrification and uptake by plants as the major routes of attenuation in nitrate loaded
environments.
Dissimilatory nitrate reduction to ammonia (DNRA) represents an alternate fate
for nitrate in the environment. DNRA transforms nitrate to ammonia via nitrite. This
pathway tends to occur in anaerobic, carbon enriched environments (37). In certain
environments, DNRA has been shown to be the dominant form of nitrate transformation:
Christensen et al (8) demonstrated that reduction to ammonia was the dominant pathway
in carbon and nitrogen enriched sediments taken from beneath trout cages in marine fish
farms. In an aquatic environment, reduction to ammonium can lead to further
eutrophication, as opposed to denitrification, which removes nitrogen from the system.
DNRA is typically carried out as part of an electron transport chain in anaerobic
respiration by bacteria. The first step is performed by nitrate reductase. Bacterial nitrate
reductases are generally divided into three categories: membrane bound respiratory (Nar),
cytoplasmic assimilatory (Nas), and periplasmic (Nap) nitrate reductases (31).
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Periplasmic nitrate reductase
Periplasmic nitrate reductase is found in a wide variety of bacteria, including
many Proteobacteria, as well as in other gram negative and gram positive bacteria (see
appendix 1 for a full list of bacteria with nap homologues).
When the different types of nitrate reductase were first classified, membrane
bound nitrate reductase was considered the main respiratory nitrate reductase, while
periplasmic nitrate reductase was thought to function mainly in nitrate dissimilation to
oxidize excess reducing equivalents. Rhodobacter sphaeroides DSM 158 is an example
of an organism that supports this hypothesis: it contains Nap, yet cannot assimilate or
respire nitrate (24). However, further research showed that Nap does, in fact, act in
respiration in many cases. A number of nitrate respiring organisms contain only Nap,
while others, such as Escherichia coli, contain both Nap and Nar systems. When the nar
genes are knocked out in E. coli K-12, the mutant is still able to respire nitrate using Nap
(30). Work by Wang et al (39) showed that in E. coli, the two systems are
complimentary: the nap operon is expressed at low nitrate concentrations, while nar is
expressed at higher nitrate concentrations.
Periplasmic nitrate reductase has been characterized in a number of organisms.
The structures of several periplasmic nitrate reductases from Desulfovibrio desulfuricans
(10), R. sphaeroides (2), and E. coli (18) have been solved thus far. Nap from
Paracoccus pantotrophus has also been well characterized through EXAFS (4).
All prokaryotic nitrate reductases, including the periplasmic nitrate reductases, are
molybdoenzymes belonging to the dimethyl sulfoxide (DMSO) reductase family. They
contain an iron sulfur cluster [Fe4-S4], and a molybdenum atom coordinated to the
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molybdopterin guanine dinucleotide (MGD) molybdenum cofactor at the active site.
Eukaryotic organisms do not have the MGD cofactor: eukaryotic nitrate reductases
contain a molybdopterin (MPT) molybdenum cofactor, and belong to the sulfite oxidase
family, (figure 2) (34).
Protein folding and cofactor incorporation of periplasmic nitrate reductase occurs
in the cytoplasm. In most cases, the folded protein contains a twin argenine motif on the
N-terminus, which facilitates its translocation to the periplasm via the twin argenine
translocator system (41). Once NapA has been transported to the periplasm, it complexes
with NapB (except in D. desulfuricans, which contains only the monomeric protein, and
possibly Desulfitobacterium hafniense, whose genome does not appear to contain a napB
gene).
The nap operon is highly variable between bacteria, not only in the gene order but
also in which genes are present. The order and composition of the nap operon in
representative organisms is shown in figure 3. In addition to the catalytic subunit NapA,
which is always present, and NapB, which is present in most organisms studied, the
operon can contain napC, D, F, G, H, K, and L. Three of these are involved in electron
transfer: the c-type tetra-heme membrane anchored protein NapC, and the ferrodoxins
NapG and NapH. The rest are either involved in protein assembly and translocation, or
are of unknown function (12).
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Figure 2: Active site of the SO and DMSO families. All known prokaryotic nitrate
reductases belong to the DMSO family (A and B). Eukaryotic nitrate reductases belong
to the SO family (C). Source: Tavares et al (34).

Figure 3: Gene composition and order of selected bacteria. In addition to the catalytic
subunit (NapA), most organisms contain the NapB subunit and a host of related enzymes
that assist in electron transport and protein folding. The members of the
epsilonproteobacteria (campylobacter and wollinella) have a unique gene order. Source:
Gonzalez (12)

6

In addition to the differences in the nap operon, napA from different sources
shows considerable variation, both in terms of sequence homology and in the structure of
the enzyme.

For example, Dd Nap is a monomeric protein, while the other Naps

characterized to date occur as a heterodimer of NapA and NapB. The Rhodobacter Nap
heterodimer is a robust unit: remaining intact throughout purification, whereas NapA and
B in E. coli are only weakly associated, and separate during purification (18).
The high level of genetic and biochemical diversity in the Nap system suggests
that periplasmic nitrate reduction functions in different ways in different organisms. Two
alternate electron pathways have been proposed for periplasmic nitrate reduction based
on the composition of the operon (12). The variation in NapA also suggests differences
in the way the protein functions to reduce nitrate.
Thus far, the Naps that have been well studied have come from the alpha-delta-
and gamma clades of proteobacteria. No Nap from an epsilonproteobacteria has been
well characterized. Analysis of the gene sequence shows that napA from the
epsilonproteobacteria form a distinct group apart from the naps of other proteobacteria,
as illustrated in figure 4. Given the diversity of Naps from the other groups, this genetic
diversity suggests that the epsilon Naps may be significantly different from other Naps in
their structure and mode of action. The characterization of a Nap from an
epsilonproteobacteria can be expected to yield valuable information that will aid in
understanding the diversity of the Nap system.
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Figure 4: Distance tree of Naps in Proteobacteria (next page). Light blue
=alphaproteobacteria, green=betaproteobacteria, yellow=gammaproteobacteria,
pink=eubacteria, red=enterobacteria, dark blue=epsilonproteobacteria. The
epsilonproteobacteria form a distinct branch of the tree. Source: NCBI database protein
BLAST search. The tree was built with a maximum sequence difference of 0.75.
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Epsilonproteobacteria
The epsilonproteobacteria are a metabolically and ecologically diverse group.
The class contains only one order, Campylobacterales, which divided into three families:
campylobacteraceae, helicobacteracea, and nautiliaceae. Members of
campylobacteraceae and helicobacteracea are found in soil, aqueous environments, and
in humans and animals: many members in both families are pathogens: Campylobacter
species can cause acute enteritis and reproductive disorders, while Helicobacter species
have been linked to the formation of peptic ulcers (22). The nautiliaceae are anaerobic
marine thermophiles.
Campylobacter and Helicobacter are the best known genera in the
epsilonproteobacteria. Both contain many pathogenic species, and have been well
studied for this reason. The helicobacteracea family contains the Helicobacter and
Wolinella genera. Many members of the Helicobacter are pathogenic: Wolinella contains
only one species, which is found in cow rumens, and is not pathogenic.
In addition to Campylobacter, the Campylobacteraceae family contains the
Arcobacter and Sulfurospirillum genera. The Arcobacter are diverse, with species
ranging from pathogens to plant-associated nitrogen fixers (11).

Sulfurospirillum barnesii
The Sulfurospirillum genus is most closely related to Campylobacter, and consists
of free living species found in freshwater and marine environments. They are micro
aerobic, and can use succinate, fumarate, formate, malate, and pyruvate as electron
donors during respiration (some species can use lactate as well). As acceptors, different
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members of the genus can use elemental sulfur, sulfite, thiosulfate, trimethylamine oxide,
Fe(III), DMSO, arsenate, selenate, nitrite, and nitrate. The genus currently has six known
species, including Sulfurospirillum barnesii.
S. barnesii was placed in the genus only after 16S RNA analysis (32). It was
isolated from a selenate contaminated freshwater marsh in Nevada, and originally given
the genus name Geospirillum (26). It is gram negative, 0.3 µm wide and 1-2 µm long,
with a polar flagellum. Its optimal growth is at 33oC, pH 7.5, 0.05% NaCl. It can use
elemental sulfur, thiosulfate, trimethylamine oxide, Fe(III), arsenate, selenate, nitrite, and
nitrate as its electron acceptors. Selenate is reduced to elemental selenium, and nitrate is
reduced to ammonium (32).
S. barnesii was originally discovered due to its production of elemental selenium,
which makes it of interest from the environmental perspective. However, the nitrate
reductase from S. barnesii is of particular interest due to its relationship to the pathogenic
members of the epsilonproteobacteria. S. barnesii nap operon is in the order
napAGHBFLD. This order is similar to that in other epsilonproteobacteria:
Campylobacter jejuni lacks napF, but otherwise has the same order. The napA of S.
barnesii has a sequence significantly different from that of previously characterized naps,
and similar to those in other epsilonproteobacteria. Characterization of a periplasmic
nitrate reductase from the epsilonproteobacteria would add to our understanding of the
Nap enzyme, and also to our understanding of the pathogenic species in the class.
One method of gaining a better understanding of the function of NapA in S.
barnesii is through mutagenesis studies. Hettmann et al (14) were able to demonstrate
the importance of a lysine residue at the active site of the NapA from Ralstonia eutropha.
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The residue is highly conserved not only in periplasmic nitrate reductases, but in formate
dehydrogenases as well. Hettman et al replaced the lysine residue with both uncharged
and charged residues to determine its function in the active site. They found that
replacing the lysine with a charged residue resulted in a mutant with only 23% of wild
type activity. Such studies can answer questions about the mode of action of the catalytic
site, dimerization, and coordination of cofactors.
As S. barnesii is not amenable to genetic manipulation, site directed mutagenesis
requires transfer of the napA gene into a different system for mutagenesis and expression.
Several systems can be used for genetic manipulation and heterologous expression: the
most common method is insertion of a plasmid into E. coli.

Heterologous expression of molybdoenzymes
A number of groups have been successful in over expressing molybdoenzymes in
bacterial hosts. The systems used are variable, including expression in Rhodobacter (19),
and expression of a eukaryotic nitrate reductase in the yeast Pichia pastoris (38).
Expression in E. coli has also been used, with varying success. E. coli has several
advantages over other host organisms: it is easy to genetically manipulate, and it can
synthesize the MGD cofactor, which eukaryotic systems cannot do.
Over-expression of proteins in E. coli is a well established technique in molecular
biology, and has been successful in many cases. However, heterologous expression,
especially of active enzyme, can pose a challenge. In order to express functional NapA
from S. barnesii in E. coli, several possible issues must be considered. As discussed
above, NapA is a molybdoenzyme in the DMSOR family, and contains both an MGD
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cofactor and an iron-sulfur cluster. If a functional enzyme is to be obtained, the protein
must be correctly assembled with the MGD cofactor and the iron sulfur cluster.

The molybdenum cofactor in E. coli
In order to manufacture the active form of NapA, the molybdenum cofactor must
be present. Eukaryotic molybdoenzymes use the molybdopterin cofactor . Most
prokaryotic molybdoenzymes, including NapA, require a modified form, the
molybdopterin guanine dinucleotide (MGD) cofactor (13). In E. coli, MPT is
synthesized first, then converted to MGD by MobA (figure 5)(36).
Although many of E. coli’s molybdoenzymes are anaerobic respiratory enzymes,
the MGD cofactor is made under both aerobic and anaerobic conditions (1).
Theoretically, this should allow heterologous expression of molybdoenzymes in E. coli
under aerobic or anaerobic conditions.
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Figure 5: Modification of the MPT cofactor to form MGD. MobA adds the
nucleotide to the MPT cofactor to form MGD. Most prokaryotic enzymes use the MGD
cofactor. Most cofactor present in E. coli is in the MGD form. Source: Temple,
Rajagopalan (36).
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Previous molybdoenzyme expression studies
Most molybdoenzymes expressed in E. coli to date have been either homologous
expression of E. coli proteins or expression of eukaryotic members of the sulfite oxidase
family. While the enzymes of this family are related to those in the DMSOR family, the
sulfite oxidase family contains the molybdenum in an MPT, rather than an MGD
cofactor. In E.coli, MPT is a precursor to MGD; many of the eukaryotic studies use E.
coli strains that express higher levels of MPT.
Temple, Graf, and Rajaagopalan (35) achieved high level expression of a
eukaryotic molybdoenzyme, human sulfoxide reductase, with an average yield of 15.1
mg/L. They used a vector with a trc promoter and a 6x his tag on the N-terminus. They
used the E. coli strain MC4100 and its derivative TP1000, which lacked MobA, which
converts the MPT cofactor to MGD. The cells were grown aerobically in Mo
supplemented LB and expressed with 20uM IPTG at 30oC for 16-18 hrs. Their
experiments with BL21(DE3) gave a higher total protein yield, but a much lower activity
levels. The reason for the low activity may be related to the lack of the MPT cofactor: in
E. coli strains containing MobA, most of the MPT is converted to MGD.
Pollock et al (28) expressed assimilatory nitrate reductase from spinach in both
BL21(DE3) and TP1000. Expression levels were similar in both strains: about 1.5 mg/L
for both strains. TP1000 activity levels were higher, but this can be attributed to the
higher concentration of MPT cofactor due to the mobA deletion. The pET28 system was
used in BL21(DE3), which incorporated a His tag on the N-terminus. Expression was
performed aerobically in Terrific Broth for 16-18 hrs at room temperature and
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anaerobically in “anaerobic media” containing NZ amine, salts, and fumaric acid at room
temperature for 24 hrs.
Heterologous expression of prokaryotic molybdoenzymes in E. coli has been
successful in only two cases. The first is biotin sulfoxide reductase from Rhodobacter
spharoides. Pollock and Barber (27) were able to recover about 0.125 mg/L using a
pGex vector in E. coli strain JM109 and a 4 hour induction at 24oC in LB. The recovered
enzyme had a high rate of cofactor incorporation and good activity. However, E. coli
also possesses a biotin sulfoxide reductase with a very similar sequence, which may
facilitate expression.
The second example of a successfully over expressed molybdoenzyme in E. coli
is also from Rhodobacter: Hilton, Temple, and Rajaagopalan (15) expressed R.
sphaeroides Dimethyl Sulfoxide Reductase in E. coli strain BL21(DE3) using pET-28
and pET-29 expression systems. They determined that the optimal expression of active
enzyme was obtained by removing the periplasmic signal sequence and adding an Nterminal 6X his tag. The optimal expression conditions were growth in M9ZB broth
supplemented with fumaric acid, glucose, Na2MoO4, and 80 µM IPTG, anaerobically at
room temperature for 24 hrs. Under these conditions, they recovered about 0.5 mg/L
active protein. The published results do not show a gel of the induction, only western
blot analysis.
Both successfully expressed proteins came from R. sphaeroides. Attempted
expression with proteins from other sources has been less successful. Baas and Retey (3)
attempted expression of pyrogallol-phloroglucino transhydroxylase from Pelobacter
acidigallici using both pT-7 and a pQE 30 expression systems. In both cases, they
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obtained high levels of protein yield – up to 30% of total cellular protein. Unfortunately,
all the peptide was in inclusion bodies which could only be solubilized by boiling in 1%
SDS. Attempts to extract active enzyme by gentler methods or refold the enzyme with
the cofactor failed. They concluded that homologous expression may be a more
promising route.

Expression of epsilonproteobacteria proteins
Like expression of molybdoenzymes, expression of enzymes from
epsilonproteobacteria has been successful in several cases. McClain and Cover (23) were
able to successfully express a vacoulating toxin from Helicobacter pilori using a pET
vector with a T7 expression system. The induction was performed at room temperature
in Terrific Broth and 250 µM IPTG induction for 20 hours. The level of induction was
not quantitatively determined; the expressed protein was detected by immunoblotting and
activity assays.
Roncarati et al (29) were also successful in expressing a Helicobacter protein.
They were able to heterologously express the membrane associated HrcA repressor
protein in E. coli BL21 using the pET expression system. They were initially
unsuccessful due to difficulties with toxicity and solubility. These problems were
overcome by adding a heat shock step of 90 minutes at 42oC prior to a 4 hour induction in
LB with 1 mM IPTG.
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The pET expression system
The pET vectors
The Champion pET expression system from Invitrogen is based on the expression
vector developed by Studier (33). The pET vectors contain the T7lac promoter, which is
recognized by the strong bacteriophage T7 RNA polymerase. This promoter is capable
of producing large amounts of protein when the polymerase is present. In the pET
expression systems provided by Invitrogen (Carlsbad, California), T7 polymerase is
provided by the host strain. The presence of the polymerase in the expression strain leads
to some basal expression of the gene under T7 control. To reduce basal expression, pET
vectors include a lac operator sequence downstream from the T7 promoter. The operator
serves as a binding site for the lac repressor (encoded by lacI in the vector, figure 6),
which reduces basal transcription of the gene of interest in the absence of IPTG.
The pET vectors also contain an antibiotic resistance marker conferring either
kanamycin or ampicillin resistance, and one or more tags to identify and purify the
expressed protein. pET101/D-TOPO contains a V5 epitope and a 6x histidine tag
designed to be transcribed on the C-terminus of the gene product for antibody detection
and affinity purification (Figure 6).

Directional TOPO cloning
The Invitrogen TOPO cloning system uses Topoisomerase I from Vaccinia virus.
Topoisomerase cleaves the phosphodiester backbone and binds to the DNA after the
sequence 5′-CCCTT. The binding can be reversed by the 5′ hydroxyl of an incoming
DNA strand.
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The TOPO cloning vectors contain the 5′-CCCTT sequence on both sides of the
cloning site. Topoisomerase I binds to both sequences, which prevents self annealing of
the linear vector. Topoisomerase I is then displaced by an incoming blunt-end PCR
product. Because the vector does not close on itself, the majority of the plasmids taken
up by the competent cells contain an insert, which eliminates the need for blue/white
screening.
The vector also contains a 3′-GTGG overhang on the front end of the cloning site.
The PCR product is the designed with a CACC sequence at the 5′ end. During the
cloning reaction, the vector overhang anneals to the complimentary sequence of the
incoming PCR product, stabilizing the insert in the desired orientation. Under optimal
conditions, this method can achieve greater than 90% efficiency of cloned products in the
correct orientation.

E .coli expression and the BL21 Star (DE3) expression strain
BL21 Star (DE3) is an E. coli B/r strain and has the genotype F- ompT hsdSB (rBmB-) gal dcm rne131 (DE3). DE3 indicates the presences of the λDE3 lysogen, which
carries the gene for T7 RNA polymerase under the control of the IPTG inducible lacUV5
promoter. The T7 polymerase gene is inserted into the phages int gene, preventing its
entry into the lytic cycle.
The BL21 strain does not contain the lon protease, and also carries a mutation in
the outer membrane protease ompT. In addition, BL21 Star carries a mutated rne gene,
which lacks mRNA degrading capabilities.
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Figure 6: Map of the pET101 TOPO vector from Invitrogen. The T7 promoter is
tightly regulated by the lacO operator directly downstream, which is regulated by the
product of lacI, also encoded by the plasmid. The Topoisomerase at the cloning site
allows for fast cloning reactions. If the cloned gene is inserted in the correct frame and
without a stop codon, transcription will continue, and the resulting peptide will contain
the V5 epitope and a tag of six histidine residues at the C-terminus for identification and
purification. Source: Invitrogen manual (16)
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The pLysS plasmid
The BL21 Star (DE3) pLysS strain contains the pLysS plasmid, which encodes
the gene for T7 lysozyme. The lysozyme binds to T7 RNA polymerase, inhibiting
transcription and reducing basal expression levels of the gene of interest. If the gene in
question is toxic, using the pLysS strain will allow the cells to grow to the point where
induction is possible. However, the presence of T7 lysozyme will reduce overall
expression of the gene as well.
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Objectives
Periplasmic nitrate reductases from the epsilonproteobacteria form a distinct
group within the proteobacteria. No member of this group has been characterized to date.
The NapA gene from S. barnesii is a good model for the periplasmic nitrate reductase
because it is closely related to the other epsilonproteobacteria, the organism is easier to
culture than other members of the class, and the entire sequence is known.
The objective of this project is to clone and heterologously express the S. barnesii
NapA in E. coli in order to develop a system for investigating the active site through sitedirected mutagenesis. As previous studies have been successful in expressing similar
enzymes in E. coli, we hypothesis that expression of functional NapA from S. barnesii is
possible in E. coli.
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Materials and methods
NapA primer design
The primers used to amplify napA from S. barnesii were designed based on the
complete sequence obtained by previous members of the Stolz lab. The forward primer
was designed to start after the GC cleavage site of the periplasmic signal sequence.
Hybridization was designed to begin with the AAG codon, 29 codons after the gene’s
start codon, in order to preserve the reading frame. The reverse primer began with the
codon immediately preceding the stop codon. This allowed the c-terminal his tag and V5
epitope to be transcribed.

Nucleic acid extraction from Ses-3
20 ml of a three-day culture of S. barnesii Ses-3 grown in nitrate media was spun
down at 7000 x g, then rinsed and resuspended in 1.6 ml lysis buffer (50mM EDTA,
0.1M NaCl, pH 7.5). 180µl lysozyme (0.1g/ml in lysis buffer) was added, and the cells
were incubated at 37ΟC (no shaking) for 10 min. 120 µl of 20% SDS was added, and the
tube was mixed by inverting. 2 ml of Tris-buffered phenol (pH7.9) was added, and the
tube was mixed, then separated by centrifuging at 5,000 rpm for 5 minutes. The aqueous
layer was removed, and the phenol extraction was repeated. A third phenol extraction
was performed if needed (i.e. if the lysate did not look clear). The DNA was precipitated
by adding 80 µl of 5 M NaCl and 4 ml EtOH. The mixture was incubated at -20ΟC for 3
minutes, then spun at 12,000 x g at 4ΟC. The pellet was washed with 70% EtOH, then
allowed to air dry for 1 hour, until the pellet looked dry. The DNA was resuspended in
500 µl sterile water.
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Amplification of the napA gene
The PCR reaction was performed using the following reaction mix:
10-50 ng DNA
25 pmol primer 1 (1 µM in final reaction)
25 pmol primer 2 (1 µM in final reaction)
2.5 µl 10x Pfu Turbo reaction buffer
0.5 µl dNTPs (nucleotide mix: 10mM each of dATP, dGTP, dTTP, dCTP)
0.5 µl Pfu Turbo enzyme (2.5U)
sterile water to a final volume of 25 µl
Polymerase and nucleotides were from Stratagene (LaJolla, California). Primers were
from IDT (Coralville, Iowa). The reaction was carried out using a Techne Cycler. The
cycling parameters were:
Heated lid 110ΟC
94ΟC

7 min

_____________________________
94ΟC

1 min

51ΟC

1 min

72ΟC

2 min 35 sec

X 35

_____________________________
75ΟC

7 min

4ΟC

final hold
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The efficiency of the reactions was confirmed by running 5 µl mixed with 5µl 2x dye on
an agarose gel (0.8% agarose in TAE buffer, poured with 2 µl 10 mg/ml ethidium
bromide solution/100 ml gel).
Ligation
The PCR product obtained through the method outlined above was ligated into the
pET101/D/TOPO vector using the protocols provided with the Invitrogen pET TOPO kit
(16). 5-10 ng of the PCR reaction was added in a volume of 1-4 µl to 1 µl of salt solution
and 1µl of TOPO vector, provided with the kit. Sterile water was added to a final volume
of 6 µl. The reaction mixture was incubated for 15 minutes at room temperature. The
reaction was used immediately or stored at –20ΟC until transformation.

Transformation
3 µl of the ligation reaction described above was added to a tube of OneShot
top10 chemically competent cells. The reaction was incubated for 15 minutes on ice,
then placed in a 42ΟC water-bath for 30 seconds. 250 µl of room temperature SOC media
(provided with the kit) was added and the tube was incubated at 37ΟC, 200 rpm, for one
hour. 100 µl of cells were then spread on each of two amp selective plates and 100 µl
was spread on an LB plate to verify cell viability. The plates were incubated at 37ΟC
overnight. Colonies were then transferred with a sterile toothpick to a fresh amp
selective plate with a numbered grid.
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Plasmid extraction
Plasmid extraction was performed using the Promega Wizard SV DNA column
purification kit from Promega (Madison, Wisconsin). Single or pooled colonies were
grown overnight in 10 ml LB-amp media. The culture was then spun down at 7,000 rpm
for 5 minutes. The pellet was then resuspended in 250 µl of cell resuspention buffer. 250
µl of lysis buffer was added, and the mixture was incubated for 3-5 minutes. 10 µl of
alkaline protease was added, followed by another 5 minute incubation period.
Neutralization solution was then added, and the tubes were spun at 12,000 rpm for 15
minutes. The supernatant was removed to a fresh tube and spun a second time under the
same conditions. The supernatant from the second spin was added to the column. The
column was washed twice with wash buffer, and the plasmid was eluted with 100 µl
nuclease free water. Concentration and purity of the plasmid was determined using 260
and 280 nm spectrophotometer readings: a 260/280 ration of 1.7-1.9 indicated a relatively
pure sample.

Restriction digest
To verify the identity and orientation of the insert, restriction digest with sacI was
performed on the purified plasmids. Reagents were obtained from Promega. 9 µl of
purified DNA (100-130 ng/µl) was combined with 2 µl buffer (buffer J, 10 x), 0.2 µl
BSA (10mg/ml), 1 µl SacI (10U/µl), and 7.8 µl sterile water. The reaction was incubated
in a 37ΟC water bath for 1-2 hour, then frozen. 4 µl of 6x DNA loading dye (Promega)
was added, and the samples were run on a 0.8% agarose gel.
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PCR confirmation
To confirm the orientation of the insert, directional PCR was used. The forward
primer was designed to hybridize with the plasmid about 40 bases before the cloning site,
and the reverse primer was designed to hybridize about 460 bases from the 5’ end of the
napA gene. Buffer, nucleotides, and Taq were from Promega. The reaction mixture was
as follows:
25-65 ng DNA,
1 µl Nucleotide mix,
10 µl 2.5 x buffer,
1 µl of the forward primer
1 µl reverse primer (~20mM concentration)
0.25 µl Taq polymerase (10 units/µl)
sterile water to a final volume of 25 µl.

The cycling parameters were as follows:
Heated lid 110ΟC
_____________________________
95ΟC

30 sec

50ΟC 30 sec
70ΟC

X 35

1 min

_____________________________
72ΟC

75min

4ΟC

final hold
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An alternate procedure was also used using PCR RedMix from GeneChoice (Fredrick,
Maryland). A single colony was picked from the plate with a sterile toothpick, and
spread inside a PCR tube. 1 µl of each primer was added, 12.5 µl of RedMix, and water
to 20 µl. The reactions were heated at 96oC for 10 minutes before using the program
described above.

DNA Sequencing
Primers for sequencing were designed using MacVec. The reactions were
performed using the BigDye system from Applied Biosystems (Foster City, California).
The following reaction mixture was used:
15-20 nmol primer
200-300 ng plasmid
2 µl BigDye solution
6 µl 2.5X buffer
sterile water to 20 µl.
The reaction was performed on a DNA Engine Dyad Peltier thermal cycler from
MJ Research (Waltham, Massachusetts) under the following conditions:

Heated lid 100oC
95oC 1 min (ramp to 95o at 1oC/min)
______________________________________
95oC 30 sec (ramp to 95oC at 1oC/min)
50oC 5 sec (ramp to 50oC at 1oC/min) X 74
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60oC 4 min (ramp to 60oC at 1oC/min)
_______________________________________
10oC Hold
The completed reaction was then passed through a Centricep column (Princeton
separations, Adelphia, NJ) filled with 800 µl Sephadex G-50 (Sigma) suspended in sterile
nanopure water at a concentration of 0.7 g/ml. The columns were allowed to drain, the
spun at 750 x g for 2 minutes to remove interstitial fluid. The sequencing reaction was
loaded onto the column and spun at 750 x g for 2 minutes. The collected sample was
then dried in a SpeedVac until dry, resuspended in 20 µl di formamide (Sigma), heated to
95oC for 2 minutes, and sequenced using a 3100-Avant Genetic Analyzer. Sequences
were examined in Chromas, and aligned to the known napA sequence using ClustalW.

Insertion of Kanamycin resistance
Kanamycin was inserted to replace ampicillin in the construct because it is a more
reliable antibiotic. Replacement was preformed using phage transformation with the λ
phage λNk1105 (λcI857, b522, Pam80, Δkan, ptac-rtnpase). A stock of λ lysate was
used to make 7 dilutions from 10 to 10-7 in TMG buffer (appendix 2). 0.1 ml of each
dilution was added to 0.1 ml of an overnight culture of E. coli LE392. The mixture was
incubated at RT for 10 minutes, then 2.5 ml of molten top agar was added and the
mixture was poured over a TB1 agar plate. The plates were incubated overnight and
37C. The next day, individual plaques were added to 0.1 ml fresh overnight LE392
culture. 5 ml TBMM broth was added, and the tubes were incubated with rotating at 37C
for 4-6 hours, until the cells began to lyse. 10 drops of chloroform were added, the tubes
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were spun down for 20 minutes at 35,000 rpm, and the supernatant was transferred to a
sterile glass tube and 10 more drops of chloroform was added. The lysate titer was tested
by rediluting and spotting 10 µl of each dilution onto TB1 plates overlaid with top agar
containing 0.1 ml overnight culture of LE392. The next morning, the plaques were
examined, and the titer was estimated by determining which dilution yielded a countable
number of plaques.
The fresh lysate was then used to infect Top10 cells containing the construct.
Equal amounts of overnight cells and lysate were mixed and incubated at 37oC for 30
minutes. The reaction was diluted 1:5 in LB broth and incubated with shaking for 30
minutes. The cells were then spun down to concentrate them, resuspended in 400 µl LB
broth, and spread on two LB-kan plates. The plates were incubated overnight.
The next morning, the colonies were removed from the plate by washing with 7
ml of 50 mM sodium citrate in LB broth. The resulting cells were spun down, and the
plasmid was extracted as described above. The plasmids were then retransformed into
Top10 cells, and grown on LB-kan plates. Single colonies were selected and spotted onto
LB-kan and LB-amp plates with a sterile toothpick. Colonies that were kanamycin
resistant and ampicillin sensitive were selected, and confirmed by performing PCR on the
insert and through restriction analysis, as described above.

Site Directed Mutagenesis
Site directed mutagenesis was performed using the QuikChange Site directed
mutagenesis kit from Stratagene. Mutagenesis primers were designed using Stratagene’s
primer design program (http://www.stratagene.com/tradeshows/feature.aspx?fpId=118).

29

The resulting primers were purchased from IDT DNA, with standard desalting.
Mutagenesis was carried out according to the protocol provided by Stratagene. The
following reaction mixture was used:
5 µl of 10 x reaction buffer
10 ng plasmid
125 ng primer 1
125 ng primer 2
1 µl dNTP mix
3 µl QuikSolution
Sterile nanopure water to a final volume of 49 µl
1 µl PfuUltra HF DNA polymerase (2.5 U/µl)
The PCR cycling parameters were:
Heated lid 110oC
95oC 1 minute
____________________________
95oC 50 seconds
60oC 50 seconds

X17

68oC 8.5 minutes
____________________________
68oC 7 minutes
10oC hold
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The resulting PCR product was digested with Dpn I restriction enzyme to digest the
template plasmid. 1 µl of Dpn (10 U/µl) was added to the PCR mix, and the reaction was
incubated at 37oC for 1 hour. The digest was then transformed into XL10-Gold
Ultracompetent Cells. 45 µl of cells were aliquoted into prechilled BD Falcon
polypropelene tubes BD biosciences, San Jose, California). 2 µl of β-ME mix was added
and the cells were incubated on ice for 10 minutes with swirling every 2 minutes. 2 µl of
the digested plasmid reaction was added, and the cells were incubated on ice for 30
minutes. The cells were then heat shocked at 42oC for 30 seconds, placed back on ice for
2 minutes, and 500 µl of 42oC SOC media was added to the tube. The reaction was then
incubated at 37oC for 1 hour with shaking. 250 µl of the reaction was plated on each of 2
Amp selective plates. The plates were incubated overnight. The next morning, 4
individual colonies were streaked out on fresh Amp plates and cultured overnight in
liquid media. Plasmid was isolated from the colonies, and the mutated site was
sequenced using the appropriate primer.

Pilot Protein Expression
To express the NapA in E. coli, the construct was transformed into BL21 Star
(DE3). The competent cells were thawed on ice, and 5-10 ng of plasmid was added to
the vial. The cells were incubated for 10 minutes, then heat shocked in a 42ΟC water bath
for 30 seconds. The tubes were transferred to ice for several minutes, then 250 µl of
S.O.C. solution was added, and the tubes were incubated with shaking for 30-60 minutes.
The entire reaction was transferred to 10 ml LB broth with antibiotic and grown
overnight at 37oC with shaking.
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The next morning, 500 µl of the overnight culture was transferred to 10 ml of
fresh LB with antibiotic. The culture was grown until the OD600 was about 0.8. The
culture was then divided into two 5 ml cultures, and one was induced by adding IPTG
(Promega) to a final concentration of 1 mM. The cultures were grown for 3-6 hours with
300 µl samples taken every half hour. The samples were brought to a volume of 1 ml,
and the absorbance was taken at OD600. The absorbance was used to standardize the
amount of sample run on the gel: a reading of 1.0 corresponded to 10 µl loaded on the
gel. The samples were then spun at maximum speed for 20 seconds, and the supernatant
was poured off. The cell pellet was resuspended in 50 µl 10 mM Tris pH 7.5 and 50 µl
Laemmli sample buffer from BioRad (Hercules, California), and boiled at 90oC for 5
minutes. If necessary, the samples were pipetted with a 200 µl pipette to cleave the
nucleic acids. The samples were then run on a polyacrylamide gel as described below. If
the OD of the samples was low, the pellet was resuspended in 50 µl sample buffer (no
Tris), and an OD of 0.5 corresponded to 10 µl loaded on the gel.

Scaled-up protein expression
BL21 Star (DE3) cells were transformed and grown overnight as described for the
pilot expression. The next morning, 1 ml of the overnight culture was transferred to a
flask with 50 ml LB containing the appropriate antibiotic. The culture was grown to an
OD600 of 0.9, and induced with 1 mM IPTG. The induced culture was grown for 2.5
hours, and harvested by spinning at 5200 x g for 7 minutes. The pellet was rinsed once
and resuspended in 4 ml native purification buffer (100 mM NaCl 500 mM phosphate),
and French pressed to lyse the cells. Protease inhibitor cocktail from Sigma-Aldrich was
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added at a concentration of 1 mg/ml of culture. Glycerol was added to a final
concentration of 5% and the lysate was stored at -80oC.

Anaerobic Expression
Anaerobic expression was conducted in LB media degassed with N2 and enriched
with 20 mM lactate, 14 mM DMSO, and 1 mM sodium molybdate. The supplements
were added after autoclaving.
BL21 Star (DE3) cells containing the insert were transformed as described above,
and grown aerobically overnight. The next morning, 500 µl of overnight culture was
inoculated in 5 ml LB media and grown anaerobically to an OD600 of 1. The culture was
then diluted 1:20 in the anaerobic media. The appropriate antibiotic and was also added.
The cultures were induced IPTG at a final concentration of 50 µM immediately after
inoculation. The bottles were then shaken at room temperature. For the pilot inductions,
1 ml samples were taken at 16, 18, and 24 hours, and processed as described above for
the aerobic pilot expression.

Chloramphenicol pulse-chase
Cells were induced as described above for pilot expression. After 2 hours,
chloramphenicol was added to a final concentration of 200µl/ml, and incubation
continued at 37oC with shaking for 4 more hours. Samples were taken as described
above for pilot induction.
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SDS-PAGE protein gel
SDS-PAGE gels were run using the BioRad (Hercules, California) system.
Protein samples were diluted 1:1 with Laemmli sample buffer containing βmercaptoethanol, then incubated at 85ΟC for 5 minutes (if whole cells were used, samples
were prepared as described above). The samples were then loaded on a BioRad precast
gel (12% Tris-HCl) and run in a Tris-glycine buffer with 10% SDS at 70-75 volts until
the dye front reached the bottom of the gel. The gel was then stained in coommassie for
2 hours – overnight and destained in 10% acetic acid at least 4 hours, or used in a western
blot transfer.

Western Blotting
Western blots were performed using the BioRad system and 0.45 µm NitroBind
nitrocellulose membrane from Osmonics (Minnetonka, Minnesota). The gel was run as
described above, then equilibrated in the transfer buffer (192 mM glycine, 24 mM Tris,
and 10% methanol) to remove the SDS. The membrane was hydrated in water, and then
equilibrated in transfer buffer. The sandwich was assembled using thin blotting paper,
and run at 250mA for 20-30 minutes. Transfer was verified by staining for 2-4 minutes
with Ponceau S solution from Sigma (0.1% Ponceau S in 5% acetic acid), then rinsing
with water and observing the bands. The blot was then destained in water until the bands
were no longer visible and incubated in killer filler 1-2 hrs, then in V5-antibody
(Invitrogen) diluted 1:2,000 in Killer Filler overnight. The next morning, the blot was
washed three times in Tween-Tris-buffered saline (TTBS) for 5 min each and twice in
Tris-buffered Saline (TBS) for 5 minutes each. The blot was then equilibrated in
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carbonate buffer for 2-3 minutes, and developed with 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) and Nitro-blue tetrazolium in carbonate buffer. The blots were imaged
using an HP scanner.

ProBond Column purification
Protein purification was performed under native conditions according to the
Invitrogen protocol (17) with minor modifications. The lysates were prepared as
described above in native binding buffer (50mM NaH2PO4, 100 mM NaCl). The lysate
from about 25 ml of cells was used in the column. Columns were prepared by adding 2
ml of Probond resin from Invitrogen to a column and rinsing once with 6 ml sterile
deionized water and twice with 6 ml native binding buffer. The lysate was brought to a
volume of 8 ml with native binding buffer and added to the column. The column was
then incubated for 30 min – 1 hour at room temperature with rotation to keep the resin
suspended. After incubation, the column was allowed to settle through gravity or by
centrifuging for 1 minute at 750 x g. If centrifuging was used, the resin that collected on
the side of the tube was allowed to settle for about a minute. The lysate was removed by
pipetting, and the column was rinsed 4 times with 20 mM imidazole in native binding
buffer, then eluted in 1.5 ml fractions with 250 mM imidazole in native binding buffer.
The lysate, washes, and fractions were run on a protein gel for analysis. If activity was to
be preserved, the protein containing fractions were immediately dialyzed 1:2,000 in
native binding buffer.
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Bradford Assay
The Bradford Assay was performed using BioRad’s QuickStart Bradford protein
assay kit. 20 µl of sample was added to 1 ml of room temperature dye, vortexed, and
incubated at room temperature for 5 minutes. The mixture was read at an OD of 595. A
standard curve was prepared using BioRad's pre-diluted samples. The resulting curve
and equation is shown in figure 7.

The Methyl Viologen Redox/ Greiss Assay
To measure the activity of nitrate reductase in cell lysates, a modified version of
the activity assay described by MacGregor (21) was used. Reaction mixtures of 0.9 mM
nitrate and nitrite in 3 mM methyl viologen, 50 mM Tris buffer (pH 7.1) were prepared
and thoroughly degassed with N2. Sodium dithionite was added anaerobically to a final
concentration of 1.14 mM to reduce the methyl viologen. 100 µl of cell lysate or purified
protein was added to 2.8 ml of each reaction mixture. The reaction was allowed to
continue for 1 hour, then 200 µl of the reaction was extracted for the Greiss assay. 200 µl
of 1% sulfanilamide in 5% phosphoric acid was added to each tube. The tubes were
incubated 5 minutes in the dark, and 200 µl of 0.1% NEDD in water was added. The
color was measured at 540 nm.
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BSA standard curve
1.2

y = 0.0325x + 0.0628
R2 = 0.9839
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Figure 7: Standard curve BSA protein concentration vs. OD. The equation is
displayed on the graph, and was used to estimate protein concentration in samples.
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Results
Primer design
The initial primers were designed to remove the signal sequence at the 5′ end of
the gene, and the stop codon at the 3′ end. The resulting primers are shown in figure 8.
The forward primer was labeled SeNapAF200.2 and the reverse was SeNapAR200.3.
The melting temperatures were 63.8oC and 52.6oC, respectively. SeNapAF200.2 was
designed with the CACC sequence for TOPO cloning and the ATG start codon, since the
genes original start codon was not amplified. Table 1 lists of the primers developed.

Amplification and cloning of Ses-3 napA.
The primers were successful in amplifying a 2.7 kb fragment from Ses-3 genomic
DNA (figure9a). The product was confirmed as napA through a second amplification step
using internal primers specific to napA (figure 9b). The internal amplification yielded a
2.5 kb band, the expected size based on primer location (see appendix 3 for position of
primers).
Based on the results described above, the 2.7 kb PCR product was used for
cloning with no further purification. The resulting transformation produced several
hundred clones. Of these, 106 were analyzed, and two contained the correct insert based
on the PCR and restriction enzyme analyses.
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Table 1: Primers designed for amplification, sequencing and mutagenesis.
Sequence
Primer

Tm

Amplification primers
SeNapAF200.2

CACCATGAAGGCTGCTGGTGAGCA

63.8

SeNapAR200.1

GGCTTTATAGAGCTTAACAGCA

52.6

SeNapAF200.3

CCACATGTCTCTTTCAAGAAGAGA

57.9

SeNapAR201

CGAAAACCAGCCTTCATCAT

53.3

topvecT7

ATCGGTGATGTCGGCGAT

56.6

TopPETvecF1

GCGCATAACAATTCCCCTCT

54.7

Plasmid primers

Sequencing Primers
SeNapAF202

AAGGGTATGCGGCTGCTAAG

57.5

SeNapAF203

CCTTTGGTATTGATGAGCC

50.8

SeNapAF204

CGGACCTTGAAATCATCTTCTCTC

55.2

SeNapAF205

TATGGTATGCGAACCGAG

51.5

SeNapAR206

GGGGCGTCGGTGTGTAAAGGT

61.3

SeNapAF207

CCAAGATACTGCCAATGC

51.1

SeNapAF208

GGCAGTGGGTTGAACTTTC

54.2

SeNapAF209

AAGTCTTTGGTGATGCTCG

52.7

SeNapAF210

TAAAGAGACCCAATGGCG

52.1

SeNapAF211

TGTGTTAGAGCACTGGCATAG

54.5

Mutagenesis primers
SeNapAmutF1

TACGGTAATGCCGAGCGACGCACACAACACTGGAGAC

69.1

SeNapAmutF2

GTCTCCAGTGTTGTGTGCGTCGCTCGGCATTACCGTA

69.1

SeNapAmutF3

AGGAGCCCTTCACCATGAAAGCTGCTGGTGA

67.4

SeNapAmutR3

TCACCAGCAGCTTTCATGGTGAAGGGCTCCT

67.4

SeNapAmutF4

GGAAGCTAATTGGAAATGGGATAAAGCTGTTTGCCGTT

64.2

SeNapAmutR4

AACGGCAAACAGCTTTATCCCATTTCCAATTAGCTTCC

64.2
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The PCR analysis is shown in Figure 10. To verify the correct orientation of the
insert, a primer pair designed to amplify 30bp of the vector and 460 bp of the 5’ end of
the insert were designed. The resulting product (fig 10a) shows a product running at a
low molecular weight: gels of the pooled fractions verified that the product was ~500 bp.
The original primers were used to verify the size of the insert (fig 10b).
Finally, restriction digest with sacI was used as a further confirmation of the
direction and size of the insert. The pET101 plasmid has a sacI restriction site just after
the cloning site. napA has a restriction site 1.14 Kb from the 3’ end of the gene (figure
11). The predicted result of the restriction digest, therefore, is a band at ~7.4 kb (5.7 kb
plasmid + 1.7 kb NapA) and a second band at 1.14 kb (NapA fragment).
The resulting restriction digest is shown in figure 12. Based on the restriction
analysis as well as the PCR reaction described above, C3 and C42 both appeared to
contain the construct in the correct orientation.
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Cleavage site

Figure 8: Design of Ses-3 primers. The forward primer was designed to start precisely
one codon after the signal sequence cleavage site, to preserve the reading frame. The
reverse primer was designed to exclude the stop codon and preserve the reading frame to
allow for expression of the 6x His tag and V5-epitope

a.

b.

Figure 9: a) PCR reaction using SES-3 genomic DNA and primers SeNapAF200.2
and SeNapAR200.1. b) PCR reaction of amplified product from figure 9a using
internal napA primers cjNapAF8 and SeNapR11.
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Figure 10: PCR of cloned plasmids using SeNapAF200.2 and SeNapAR200.1. lane:
1=C3, 2=41, 3=42. C3 and C42 appear to have the insert, while C41 is negative. b. PCR
of cloned plasmids using TopPEVecF1 and SeNapAR201. lane: 1=C3 amplified with
RedMix, 2=C1, 3= C1, 4=C2, 5= C3, 6=C42. Lanes 2-6 were amplified using Taq
polymerase.
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Figure 11: Diagram of pET101/D-TOPO with NapA insert and restriction
sites. The pET101/D-TOPO plasmid has a sacI restriction site 6 bases after the
cloning site. napA has a sacI restriction site that yields a 1.4kb and a 1.3kb
fragment.
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Figure 12: sacI restriction digest of constructs. Lane 1=uncut
plasmid, 2=C43, 3=C42, 4=C41, 6=C3, 7=C2, 8=C1. Both C42 and C3
show a digested fragment at ~1.3 Kb, and a second fragment at 7.4 Kb.
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Sequencing
The primers designed for sequencing using MacVec are listed in table 1 and
shown in appendix 3.
The resulting alignments are shown in figure 13. The primers were successful in
sequencing nearly the entire sequence of both inserts, with the exception of one region
later in the gene (bases 1560-1620 in figure 13). There are several mismatches with
predicted sequence at the beginning of both constructs: however, the constructs agree
with each other, and an ORF translation (shown in appendix 4) yielded the known protein
sequence. There are no deletions or insertions evident in the well sequenced areas.
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Figure 13 : Sequence alignment for C3 and C42. The sequencing verified that the
cloning site was intact and in frame. There several mismatches early on in the gene.
However, two of them do not affect the protein sequence, and the others match up to the
protein sequence data, suggesting that the published sequence was faulty. The one region
with gaps (bases 1560-1620) is due to sequencing problems: the region has few suitable
primer sites, and the data available from the sequencing reactions is uncertain.
vector
C42
C3

Vector
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42

CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 120
------------------ATCTCGATCCCGCGAA-TTAATACGACTCACTATAGGGGAAT 41
**************** *************************
CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 66
************************************************************
TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA
TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA
************************************************************
TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA
************************************************************
Cloning site
GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGAAATGGGATAA
GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAA
************************************************* ****** **
GGAGCCCTTCACCATGAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAA
************************************************* ****** **

180
101
126

240
161
186

GGCTGTTTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 300
ATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 221
**** *****************************************************
ATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAA 246
**** *****************************************************
AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 360
AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 227
************************************************************
AATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTTAACTGTATCAA 199
************************************************************
AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 420
AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 287
************************************************************
AGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCG 259
************************************************************
TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 480
TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 347
************************************************************
TATGAACGATAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCG 319
************************************************************

TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 540
TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 407
************************************************************
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C3

TGCGTTTGATGAGATGGAAAAACACATCAAAGCAGCACTTAAAGTGGGTGGGCCAGAGGC 379
************************************************************

napA
C42

GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 600
GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 467
************************************************************
GATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCGGCTGCTAAGAT 436
************************************************************

C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 660
GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 527
************************************************************
GATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTC 496
************************************************************
AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 720
AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 99
************************************************************
AGCGGTTGCAGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGA 115
************************************************************
TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 780
TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 159
************************************************************
TATTGAAATTACCGATACTATCATTACATGGGGCGCTAATATGGCAGAGATGCACCCGAT 175
************************************************************
TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 840
TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 219
************************************************************
TTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTCAAAATCGTTAA 235
************************************************************
CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 900
CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 279
************************************************************
CCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCC 295
************************************************************
AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 960
AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 339
************************************************************
AAGTACCGATTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGA 355
************************************************************
AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 1020
AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 399
************************************************************
AGCGATTGATTGGGATTTTGTTAAGAAAAATACCATTTTTACAACAGGTTTTGCGAACAT 235
************************************************************
TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 1080
TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 309
************************************************************
TGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCTGCAAAAGAACT 295
************************************************************
TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 1140
TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 369
************************************************************
TGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGC 171
************************************************************
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ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 1200
ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 63
************************************************************
ACACTTAGGTGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGC 231
************************************************************
ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 1260
ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 123
************************************************************
ACATTGGGAAATTAGCTTTGAAGATTTCAAAAAAGCTTTAGAGCCTTATACGCTGGAGTA 207
************************************************************
TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 1320
TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 183
************************************************************
TGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTCAAAGTTAAACT 267
************************************************************
TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 1380
TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 243
************************************************************
TCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAAT 327
************************************************************
GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 1440
GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 303
************************************************************
GGGCTTTAACCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTT 387
************************************************************
CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 1500
CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 444
************************************************************
CCTTTTAGGCAAACAAGCCAAACCAGGTGATGGAGCGTTTTCTCTTACAGGACAGCCAAG 447
************************************************************
TGCCTGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCNCAGATATGGA 1560
TGCATGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCGCAGATATGGA 493
*** ********************************************* **********
TGCATGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCCGCAGATATGGA 507
*** ********************************************* **********
TGTTTCCATTCCCAAACATAGAGAAGTGA GTGAAAAAATTTGGAAGCTACCTGCTGGCAC 1620
TGTTTCCATTCCCAAACATAGAGAAGTGA GTGAAAAANTTTGGAAGCTACCTGCTGGCAC 553
***************************** ******** **********************
TTTT CCNTTCCCCNACATAGAAGAAGTGNGTGAAAAA-TTTGGAAGCTACCTGCTG---- 90
* ** ** ***** ************** ***************************
ACTCAACCCAATGGGTTACCAACACATTATGAACATNCACCGTCAAATTGAGAGTGGAAA 1680
ACTCAACCCAATGGGTTACCAACACATTATGAACATTCACCGTCAAATTGAGAGTGGAAA 69
************************************ ***********************
ACTCAACCCAATGGGTTACCAACACATTATGAACATTCACCGTCAAATTGAGAGTGGAAA 78
************************************ ***********************
AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCAAGATACTGCCAATGCCAATCA 1740
AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCNAGATACTGCCNATGCCAATCA 129
************************************** ********** **********
AATCAAATTTGCATGGGTAAACGTCTGTAATCCTTACCAAGATACTGCCAATGCCAATCA 138
************************************************************

48

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

napA
C42
C3

CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 1800
CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 189
************************************************************
CTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGATGCGTATCCTGG 198
************************************************************
GATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 1860
GATTTCTGCCAA-GTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 119
************* **********************************************
GATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGG 113
************************************************************
CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 1920
CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 179
************************************************************
CTCTTACGGTAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGG 173
************************************************************
CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAAACGCTTTACGATTAAAGA 1980
CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAA-CGCTTTACGATTAAAGA 238
****************************************** *****************
CGATGCGATGAGCGATACATGGCAGTGGGTTGAACTTTCAAAACGCTTTACGATTAAAGA 233
************************************************************
CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 2040
CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 298
************************************************************
CGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATTGAAGCGGCAAA 293
************************************************************
AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 2100
AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 263
************************************************************
AGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGC 353
************************************************************
AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 2160
AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 114
************************************************************
AAAACAATTTAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGG 413
************************************************************
TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 2220
TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 174
************************************************************
TGATGCTCGAAAAGTCATGGGCAGTGATGGCAAAGAGTGGACGGGTTATGGCTTCTTTAT 473
************************************************************
TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 2280
TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 234
************************************************************
TCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGACATGACCTTGC 533
************************************************************
AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 2340
AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 294
************************************************************
AGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGA 593
************************************************************
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GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 2400
GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 354
************************************************************
GACCCAATGGCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGA 218
************************************************************
TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 2460
TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 414
************************************************************
TTTTGCTTTCTATGGTGATTTTGCAAAAGCCCTTAAAAAAGGTAACTTAGTAAAACCAAC 278
************************************************************
CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 2520
CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 82
************************************************************
CACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGACCGTACATGGA 338
************************************************************
TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 2580
TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 142
************************************************************
TCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGA 605
************************************************************
GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 2640
GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 202
************************************************************
GCACTGGCATAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGA 665
************************************************************
AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 2700
AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 262
************************************************************
AGCGCTTTGCTACATGCACCCAGAAGATGCAAAAGCAAAAGGGTTTAAACAAGGCGATAT 155
************************************************************
GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 2760
GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 322
************************************************************
GATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACCAGAGGACGTAA 215
************************************************************
TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 2820
TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 414
************************************************************
TAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAA 523
************************************************************
AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 2880
AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 474
************************************************************
AGTCTGCCTTGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGT 583
************************************************************
TAAGCTCTATAAAGCC
TAAGCTCTATAAAGCC
****************
TAAGCTCTATAAAGCC
****************
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Initial induction experiments
Initial induction experiments were performed with C3 and C42 in BL21(DE3)
and BL21(DE3) pLysS, respectively. The C3 induction had no visible induced bands.
The C42 induction had a faintly induced band at about 115 kD (fig 14). The induction
was extremely low compared to induction of the control plasmid (pET101/D/lacZ,
Invitrogen) shown in fig 15. Several possibilities for low induction were investigated,
including the possibility of codon bias.
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Figure 14: Induction experiment of C42 in BL21(DE3) pLysS. Lanes: 1=3h
uninduced, 2=3h induced, 3=4h uninduced, 5=4h induced, 6=5h uninduced, 6=5h
induced, 7=6h uninduced, 8=6h induced. The bands, indicated with arrows, are
clearly present, but faint.
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Figure 15: Induction of control plasmid pET101/D/lacZ. Lanes: 1=6h induced, 2=6h
uninduced, 3=5h induced, 4=5h uninduced, 5=4h induced, 6=4h uninduced, 7=3h
induced, 8=3h uninduced. There is a very clear, strong induction at ~120 kD. The
induction is far greater then that in C42
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Analysis of Codon Bias
Because S. barnesii and E. coli are in different classes, a difference in codon
usage between the organisms was considered a possible reason for the low expression
levels in the initial inductions. To investigate this possibility, the codon composition of
napA was compared to the codon bias in E. coli strain B. The comparison was performed
using the codon usage database from kazusa (http://www.kazusa.or.jp/codon/) based on
data from the NCBI genbank. The comparison is shown in figure 15. The bias is
significant: 19.4% of the codons in napA occur less than 1% of the time in E. coli
(colored codons, figure 16), and 4.5% occur less than 0.5% of the time (shown in red,
figure 16). Generally, the rare codons are spread throughout the gene, but in several
places, two of the rarest were clumped together. Site directed mutagenesis was done to
alter one of these clumped rare codons, at position 1687. Mutagenesis was performed,
and the resulting construct tested. The sequencing reaction was not very clear, and
showed a number of mismatches due to a poor sequencing reaction. A pilot induction
was performed despite the unclear results. The samples were TCA precipitated, in
contrast to the heat denaturation step used previously. The results are shown in figure 17.
No induced bands were visible, and the protein bands are less clear than those in the heat
prepared samples.
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Figure 16: Rare codon analysis of napA. The highlighted codons occur less than 1% of
the time in E. coli.

1 AAG GCT GCT GGT GAG CAA GCG GAA GCT AAT

1441 TAC CAA CAC ATT ATG AAC ATN CAC CGT CAA

31 TGG AAA TGG GAT AAG GCT GTT TGC CGT TTC

1471 ATT GAG AGT GGA AAA ATC AAA TTT GCA TGG

61 TGT GGT ACC GGT TGT GGT ATT ATG GTG GCG

1501 GTA AAC GTC TGT AAT CCT TAC CAA GAT ACT

91 ACC AAA GAG GGT AAA ATT GTC GCT GTC AAA

1531 GCC AAT GCC AAT CAC TGG ATT AAA GCA GCA

121 GGT GAT CCA GCC GCT CCC GTC AAT CGT GGA

1561 CGA GAG CTC GAT AAC TTT ATT GTT TGT TCC

151 CTT AAC TGT ATC AAA GGC TAT TTT AAC GCC

1591 GAT GCG TAT CCT GGG ATT TCT GCC AAA GTA

181 AAA ATT ATG TAC GGT GCG GAC AGA TTA AAA

1621 TCT GAC CTT ATT CTT CCC TCA GCA ATG ATT

211 CAA CCC CTT CTT CGT ATG AAC GAT AAA GGT

1651 TAT GAA AAA TGG GGC TCT TAC GGT AAT GCC

241 GAG TTT GAC AAA AAA GGT CAG TTT AAA CCT

1681 GAG CGA AGA ACA CAA CAC TGG AGA CAG CAA

271 GTT TCA TGG AAG CGT GCG TTT GAT GAG ATG

1711 GTC TTA CCT GTT GGC GAT GCG ATG AGC GAT

301 GAA AAA CAC ATC AAA GCA GCA CTT AAA GTG

1741 ACA TGG CAG TGG GTT GAA CTT TCA AAA CGC

331 GGT GGG CCA GAG GCG ATT GGT GTG TTT GGT

1771 TTT ACG ATT AAA GAC GTG TGG GGT GAG CAA

361 TCA GGT CAG TAC ACC ATT CAA GAA GGG TAT

1801 CCG ATT AAA GGT GGC AAG TTA CCA AAC GTC

391 GCG GCT GCT AAG ATG ATG AAG GCT GGT TTT

1831 ATT GAA GCG GCA AAA GCA ATG GGC TAC AAA

421 CGT GCC AAC GGA ATT GAT CCT AAT GCA CGT

1861 GAG ACT GAC ACC ATG TAT GAT GTT CTT TTT

451 CAC TGT ATG GCT TCA GCG GTT GCA GGC TTT

1891 GCC ACA CCA TTT GCA AAA CAA TTT AAA GCA

481 ATG CAA ACC TTT GGT ATT GAT GAG CCA GCA

1921 GAT GAT GCC ATT GGT AAA GGG TTC GAT AAC

511 GGG TGT TAT GAT GAT ATT GAA ATT ACC GAT

1951 AGT GAA GTC TTT GGT GAT GCT CGA AAA GTC

541 ACT ATC ATT ACA TGG GGC GCT AAT ATG GCA

1981 ATG GGC AGT GAT GGC AAA GAG TGG ACG GGT

571 GAG ATG CAC CCG ATT TTA TGG TCA CGT GTG

2011 TAT GGC TTC TTT ATT CAA AAA TCG ATT TGG

601 AGT GAT AGA AAA CTT ACC TCA CCT GAT CGT

2041 GAA GAG TAC CGT CAG TTT GGA TTA GGA CAT

631 GTC AAA ATC GTT AAC CTC TCA ACC TAT ACC

2071 GGA CAT GAC CTT GCA GAC TTT GAT ACG TAT

661 CAC CGC TGT TCT GAC CTT GCG GAC CTT GAA

2101 CAT AAA GTA AGA GGT TTA AAA TGG CCT GTT

691 ATC ATC TTC TCT CCA AGT ACC GAT TTG GCA

2131 GTG GAT GGT AAA GAG ACC CAA TGG CGT TTT

721 ATT TGG AAC TAT ATC GCT CGT GAG ATT GTC

2161 AAT GCA AAA TAC GAC CCG TAT GCT GCA AAA

751 TAC AAT CAT CCA GAA GCG ATT GAT TGG GAT

2191 GCA GGC AAT GGT GAT TTT GCT TTC TAT GGT

781 TTT GTT AAG AAA AAT ACC ATT TTT ACA ACA

2221 GAT TTT GCA AAA GCC CTT AAA AAA GGT AAC

811 GGT TTT GCG AAC ATT GGT TAT GGT ATG CGA

2251 TTA GTA AAA CCA ACC ACA GAA GAG ACT TAT

841 ACC GAG GCT GAG GCT AAA AAA TTA GGC TAT

2281 TCA CTT AAA AAT AAA GCA AAA ATC TTC TTT

871 TCT GCA AAA GAA CTT GAA GTC ATT AAA AAA

2311 AGA CCG TAC ATG GAT CCA TGT GAA ATG CCA

901 GAA GAT GCC AAA GTC ATT TCT GAA AAA GAA

2341 GAT CGT GAG TAC GAT ACA TGG CTA TGT ACA

931 GCT CCA GGT CTT GCA CAC TTA GGT GTC AAA

2371 GGA CGT GTG TTA GAG CAC TGG CAT AGT GGT

961 GCA GGC GAT GTT ATG AAA ATG GAC AAA GCA

2401 ACG ATG ACC ATG AGG GTA CCT GAA CTT TAC

991 GAT GCA GCT GGT GCA CAT TGG GAA ATT AGC

2431 CGT GCC GTT CCT GAA GCG CTT TGC TAC ATG

1021 TTT GAA GAT TTC AAA AAA GCT TTA GAG CCT

2461 CAC CCA GAA GAT GCA AAA GCA AAA GGG TTT

1051 TAT ACG CTG GAG TAT GTC GCA AAG ATT TCT

2491 AAA CAA GGC GAT ATG ATT TGG TTA GAG AGT

1081 AAA GGT AAT CCC GAT GAA AAA CTA GAAGAT

2521 CGT CGA GGT TCA TGT AAA GCC CGT GTT GAA

1111 TTC AAA GTT AAA CTT CAA GAA CTT GCC AAT

2551 ACC AGA GGA CGT AAT AGA ACG CCT CGT GGA

1141 CTT TAT ATT GAA AAA AAT AGA AAA GTC GTT

2581 TTG GTG TTT GTT CCA TGG TTT GAT GAG AAG

1171 AGT TTC TGG ACA ATG GGC TTT AAC CAG CAC

2611 GTT ATG ATT AAT AAA GTC TGC CTT GAT GCA

1201 CAA AGA GGC ACA TGG GTT AAT GAG CAG TCC

2641 ACG TGC CCG ATT TCA AAA CAG ACC GAT TAT

1231 TAC ATG GTT CAC TTC CTT TTA GGC AAA CAA

2671 AAA AAA TGT GCT GTT AAG CTC TAT AAA GCC

1261 GCC AAA CCA GGT GAT GGA GCG TTT TCT CTT

2701 TAA

1291 ACA GGA CAG CCA AGT GCC TGT GGA ACTGCA
1321 CGT GAA GTA GGT ACC TTT ACA CAC CGA CTC
1351 CCC NCA GAT ATG GAT GTT TCC ATT CCC AAA

Occurrence per 1000 in E. coli:
2-4.9

5-7.9 8-10

1381 CAT AGA GAA GTG AGT GAA AAA ATT TGG AAG
1411 CTA CCT GCT GGC ACA CTC AAC CCA ATG GGT
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Figure 17: Induction of mutated construct with TCA precipitation.
Lane: 1=4h induced, 2=4h uninduced, 3=3h induced, 4=3h uninduced,
5=2h induced, 6=2h uninduced, 7=1h induced, 8=1h uninduced.
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Induction in Rosetta of C42 and MK75
After the induction of the mutated plasmid, induction in the Rosetta2 cell line was
attempted. The Rosetta2 strain contains a BL21 (DE3) pLysS background, with the
plasmid pRARE, which contains tRNAs for the rare codons AGG/AGA, CGG, CGA,
GGA, AUA, CUA, and CCC.
Induction of C42 in Rosetta cells showed a slightly clearer, stronger looking band
(figure 18). The induced bands were visible in the samples prepared by boiling whole
cells in SDS, but not in samples prepared by TCA precipitation (lanes 6-7). Although the
band was stronger, the induced band did not approach the strength of the control
induction.
The C42 plasmid was then altered by replacing the ampicillin resistance with
kanamycin resistance and using site directed mutagenesis to convert the first rare codon
to a common one (see appendix 3 for position). The resulting construct was called
MK75. When MK75 was induced in Rosetta cells, the induced band was clearly
observed. However, none of these measures increased the induced band to the expected
induction levels.
The induced bands from the gel in figure 18 appeared clearly enough to be cut out
and analyzed with MALDI-MS. The MALDI was performed by Dr. Paul Reynolds.
Analysis of the resulting spectra identified the induced protein as β-galactosidase.
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Figure 18: Induction of C42 in the Rosetta strain. Lanes: 1=1h uninduced, 2=1h
induced, 3=2h uninduced, 4=2h induced, 5=3h induced, 6=3h uninduced, 7=3h
uninduced with TCA precipitation, 8=3h induced with TCA precipitation. The TCA
precipitation method gave poor results, but an induced band is clearly visible in the heatprepared samples.
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Western blot analysis of inductions
Following the realization that the induced band seen was not NapA, a western blot
of an induction with C42 from 4-6 hours in Rosetta pLysS cells using an antibody to the
V5-epitope was performed. The resulting blot (figure 19) showed very weak expression
of multiple bands in both the induced and uninduced fractions. Lanes 10-15 show
induction of the pET101/D/lacZ control plasmid (Invitrogen) in BL21(DE3) cells. A blot
of an induction of C3 in BL21Star (DE3), however, showed stronger bands only in
induced fractions.

Inductions in different cell lines
In order to test efficacy of the cell lines, induction experiments using the construct
C3 in BL21star (DE3), BL21star(DE3) pLysS, and Rosetta2 pLysS were conducted. All
three inductions were harvested at 3 hours, and the resulting samples were blotted with
the V5 epitope antibody. The results (figure 20) show a stronger induction in
BL21star(DE3), a weak induction in BL21star (DE3) pLysS, and a weak non-induced
expression (present in both induced and uninduced samples) in Rosetta. Based on these
results, BL21star (DE3) was used in further experiments.
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Figure 19: a) Ponceau stain of blot and b) developed western. Lanes:
1=C42 4h uninduced, 2=C42 4h induced, 3=C42 5h uninduced, 4=C42 5h
induced, 4=6h uninduced, 5=6h induced, 7=Rosetta without plasmid,
8=control 4h undinduced, 9=control 4h induced, 10=control 5h uninduced,
11=control 5h induced, 12 = control 6h uninduced, 13=control 6h induced.
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Figure 20: a) Ponceau of blot and b) developed western comparing the different
BL21(DE3) cell lines. Lane: 1=uninduced BL21 star (DE3), 2=induced BL21 Star
(DE3), 3=uninduced pLysS, 4=induced pLysS, 5=uninduced Rosetta, 6=induced
Rosetta, 7-8= uninduced and induced BL21 Star from a previous induction (control).

60

Product degradation
The multiple bands of expressed protein suggested that the induction product
might be degrading. To test this hypothesis, a pulse-chase experiment with
chloramphenicol was performed. Cells were induced for 2 hours, and then
Chloramphenicol was added to a final concentration of 200 µg/ml. The cells were grown
for another 4 hours, with samples taken at 1 hour, 2 hours, and 4 hours. The results
(figure 21) show degradation occurring one hour after chloramphenicol was added, with
almost total degradation by 4 hours (lanes 5-8). The control without chloramphenicol, in
contrast, remained at a steady concentration during the four hours (lanes 1-4).
The possibility that performing the induction at a lower temperature might reduce
degradation was investigated by performing a two hour induction at room temperature.
The induction levels were low, as might be expected for a short induction at lower
temperature, but the degradation pattern was unaffected.
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Figure 21: a) Ponceau of blot and b) developed western of chloramphenicol
pulse-chase induction of C3 in BL21 Star (DE3). Lanes: 1-4=no
chloramphenicol, t=0, 1, 2, 4h; lanes 5-8= chloramphenicol added, t=0, 1, 2, 4h

62

Overnight anaerobic induction
The effect of performing the degradation anaerobically was investigated using the
C3 and MK75 constructs. The resulting gels and western blots of MK75 are shown in
figure 21: results with C3 were similar. No expression is visible in the gel. The western
blot shows production of the protein at a low level. The degradation bands are still
significant, although the banding pattern is different from that in the aerobic inductions.
An aerobic induction was also performed on MK74 with 1mM sodium molybdate added
to the media. The banding pattern was the same as that for a C3 aerobic induction
without molybdenum, suggesting that the Mo does not make a difference in anaerobic
growth.

Nickel Column purification of cell lysate from C3 induction
Initial attempts to purify the induced protein using the ProBond protocol from
Invitrogen was unsuccessful: Western blot analysis showed that no protein remained on
the column following incubation (figure 22). The original protocol used a 50 mM
phosphate buffer with 500mM sodium chloride for purification. Lowering the salt
concentration to 100 mM was successful: Figure 23 shows the resulting gel, and figure 24
shows the western blot. the first fraction shows band both in the gel and western blot.
MALDI was performed on 4 bands from the gel by Paul Reynolds, and all were identified
as contaminating proteins: beta-galactosidase at 116 kD, Pyrvate Dehydrogenase at 99.8
kD, HSP 90 at 71.4 kD Chaperonin GroEL at 55 kD, and Elongation Factor Tu at 44.8
kD. The western blot band are at similar sizes to those seen in the gel: however, they are
either too weak to visualize using protein staining, or are masked by the contaminants.
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a)

b)

Figure 22: a) Gel and b) western blot of anaerobic inductions with MK75. Lanes:
1=16h uninduced, 2=16h induced, 3=18h uninduced, 4=18h induced, 5=24h uninduced,
6=24h induced, 7-8=C3 uninduced grown in1 mM sodium molybdate, 9=C3 induced (+
control), 10=MK75 3h aerobic induced with 1mM sodium molybdate.
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Figure 23: ProBond purification of induced C3 lysate, 1=lysate, 2=lysate after 1hr
column incubation, 3=wash 1, 4=wash 2, 5=fraction 1, 5= fraction 2, 6=fraction 3,
7=fraction 4, 8=fraction 4. Very little tagged protein stuck to the column, and all was
washed off in the first wash.

Figure 24: Probond purification of induced C3 lysate with 100 mM sodium chloride.
1=lysate, 2=postcolumn lysate, 3=wash 1, 4= wash 2, 5=wash 3, 6=wash 4, 7=fraction1,
8=fraction 2, 9=fraction 3, 10=fraction 4. The bands seen in lane 7 are all contaminants.
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Figure 25: western blot of ProBond purification of C3 induction with 100 mM NaCl
1=lysate, 2=postcolumn lysate, 3=wash 1, 4=wash 2, 5=wash 3, 6=wash 4, 7=fraction 1
8=fraction 2, 9=fraction 3, 10=fraction 4, 11=fraction 5, 12=fraction 6.
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Creation of a construct with the periplasmic signal sequence
Because degradation appeared to be the main problem, and proteases are not
present in the periplasm, there was the possibility that the protein might not be degraded
if expressed with the signal sequence, which would cause it to be transported to the
periplasm. A construct was therefore created that included the periplasmic signal
sequence. A forward primer was designed to begin with the napA original start codon.
The resulting primer, SeNapAF200.3, had a melting temperature of 57.9oC, and was used
with SeNapAR200.1. The resulting product is shown in figure 26. Cloning was
attempted both with the original PCR reaction and a gel purified product. Both reactions
yielded about 200 clones. Initial screening of 6 of the clones from the gel purified
reaction with the RedMix protocol showed that none of them had the insert. 50 of the
clones from the unpurified PCR reaction were screened by pooling into 5 groups of 10
and doing restriction enzyme analysis. Three of the groups had fragments of the
expected size: one of the groups, clones 11-20, was screened individually. The results
are shown in figures 27. Clone 17 had the correct restriction pattern, and was positive for
the directional PCR reaction. The PCR reaction with the original primers was extremely
weak: however, this may have been an error in setting up the reaction, as PCR using
SeNapAF200.1 was successful. To test this, the cloning site of C17 was sequenced. The
results, shown in figure 28, indicate that the 5’ end of the gene is indeed intact. Based on
these results, C17 was used in pilot expression experiments.
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a)

b)

Figure 26: a) PCR reaction with Ses-3 DNA and b) gel purified reaction. 1=reaction
with SeNapAF200.2 and SeNapAR200.1 (control), 2=SeNapAF200.3 and
SeNapAR200.1.
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a)

b)

c)

Figure 27: PCR and restriction analysis of clones from impure PCR reaction in
figure 26. a) Directional PCR. Lanes: 1=C11, 2=C12, 3=C13, 4=C14, 5=C15, 6=C16,
7=C17, 8=C18, 9=C19, 10=C20, 11=C3 (control), 12=C42 (control). Clones 14,17 and
18 are positive. b) PCR with original primers. Lanes: 1=C14 with F200.3 2=C14 with
F200.1, 3=C17 with F200.3, 4=C17 with F200.1, 5=C42 with F200.1 (+control), 6=C42
with F200.3 (-control). c) sacI restriction. Lanes: 1=C14, 2=C17. C14 did not display
the correct restriction pattern, while C17 did.
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NapA
C17

CCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAAT 120
-------------------------TCCCGCGAAATTAATACGACTCACTATAGGGGAAT 35
***********************************

NapA
C17

TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 180
TGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAATTCA 95
************************************************************

NapA
C17

GGAGCCCTTCACCATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAG 240
GGAGCCCTTCACCATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAG 155
************************************************************

NapA
C17

TGCTGCGGCTGCGGTGGGTATTGGTGTACCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGC 300
TGCTGCGGCTGCGGTGGGTATTGGTGTACCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGC 215
************************************************************

NapA
C17

GGAAGCTAATTGGAAATGGGATAAGGCTGTTTGCCGTTTCTGTGGTACCGGTTGTGGTAT 360
GGAAGCTAATTGGCGATGGGACAAATCTGTGTGCCGTTTCTGTGGTACCGGTTGTGGTAT 275
************* ****** ** **** *****************************

NapA
C17

TATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGT 420
TATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGT 335
************************************************************

NapA
C17

CAATCGTGGACTTAACTGTATCAAAGGCTATTTTAACGCCAAAATTATGTACGGTGCGGA 480
CAATCGTGGACTTAAC-------------------------------------------- 351
****************

Figure 28: Sequence alignment of C17. The cloning site is intact, as is the signal
sequence. The mismatches present are the same as those in C3 and C42.
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Induction of C17 in BL21 Star (DE3) cells
The pilot expression experiment was conducted using Bl21 Star (DE3) cells in LB
containing Amp and 1 mM sodium molybdate. The induction was allowed to proceed for
5 hrs. The resulting gel and western blot are shown in figure 29. The band at 100kD
appears stronger in the induced fractions: however, as E. coli has many proteins at this
molecular weight, the band is not isolated. The western blot clearly shows a dominant
band at 100 kD, although many degradation products are still present.
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a)

b)
Figure 29: Induction of C17. a) SDS-PAGE gel and b) western blot with anti V-5
Lanes: 1=0.5h uninduced, 2=0.5h induced, 3=1h uninduced, 4=1h induced, 5=2h
uninduced, 6=2h induced, 7=3h uninduced, 8=3h induced, 9=4h uninduced, 10=4h
induced, 11=5h uninduced, 12=5h induced. The up regulation of a band at ~100kD is
clearly visible starting at 3 hrs, indicated by the arrows in the gel.
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Probond column purification
Probond column purification using 100 mM NaCl phosphate buffer was
performed on a 5 hour induction of C17 using 50 ml of culture. The resulting western
blot and gel are shown in figure 30. The 100kD band in the gel shows up more clearly
than in the C3 lysate purification (figure 24). The strongest band in the gel does not show
up in the western blot, suggesting that it is a contaminating protein, which was confirmed
by MALDI analysis of the C3 purification. A significant fraction of the induced protein
is not binding to the column.
The concentration of protein in the fractions was measured using the Bradford
assay: however, the concentration was below the threshold for accurate detection by the
assay.
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a)

b)
Figure 30: Probond column purification of C17 a) SDS-PAGE gel and b) western
blot (b). 1=lysate, 2=postcolumn lysate, 3=wash 1, 4=wash 2, 4=wash 3, 6=fraction 1,
7=fraction 2, 8=fraction 3, 9=fraction 4.
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Discussion
Cloning and sequencing
The cloning reactions did not have the high efficiency rates expected of the TOPO
cloning system. The reason for the high level of background is most likely impurities in
the PCR reaction: small pieces of DNA with the CACC cloning end would be preferred
over the larger complete sequence.
Despite this low frequency, the two constructs obtained were clearly correct.
PCR analysis, restriction analysis, and sequencing of the entire construct and promoter
region indicated that both C3 and C42 had an intact sequence with no mutations that
would be expected to interfere with expression (i.e. frame shift mutations). C17 and
MK75 were not completely sequenced, but PCR analysis, restriction enzyme analysis,
and sequencing of the 5′ end of the cloning site verified the identity and correct
orientation of the construct. The T7 promoter region of all four clones was also
sequenced: it is intact, with no insertions or deletion that could contribute to reduced
efficiency.
The sequencing data suggests that there are several errors in the napA sequence at
the 5′ end obtained from Genome Atlantic. The discrepancy between our data and the
Genome Atlantic data leads to two changes in the protein sequence: an argenine in place
of a lysine at position 41, and a serine in place of an alanine at position 44. C3, C42,
C17, and MK75 all contain the same mismatches, obtained from multiple sequencing
reactions: we are therefore fairly confident that our data is correct. C17 represents the
first amplification of the full napA gene from S. barnesii. The N-terminal sequence from
C17 aligns with contig98 from Genome Atlantic (figure 31). The result of an open
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Contig98

CTAAGTGATAGAATCTCCTCGTAACTCAAATCAGGAGGTATCGATATGTCGCTTTCAAGA

C17clone

---------------------------------------------ATGTCGCTTTCAAGA
***************

Contig98

AGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTA

C17clone

AGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTA
************************************************************

Contig98

CCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAAATCT

C17clone

CCCGCTGAGCTTAAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGCGATGGGACAAATCT
************************************************************

Contig98

GTGTGCCGTTTCTGTGGTACCGGTTGTGGTAT-ATGGTGGCGACCAAAGAGGGTAAAATT

C17clone

GTGTGCCGTTTCTGTGGTACCGGTTGTGGTATTATGGTGGCGACCAAAGAGGGTAAAATT
******************************** ***************************

Contig98
C17clone

GTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGA
GTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGA
******************************************

Figure 31: Alignment of C17 with Contig98 from Genome Atlantic. The single
additional T present in C17 puts the sequence in frame.
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reading frame is shown in appendix 4: the protein sequence is complete, with a product of
the predicted size, indicating that there are no frameshift mutations present.

Expression
Initial induction with C3 and C42 did not produce any visible induction in BL21
Star (DE3) cells induction of C42 in the pLysS strain produced what appeared to be a low
level induction of a band at ~115 kD. This band was taken as evidence of plasmid
induction, and further experiment were aimed at increasing the intensity of this band.
We considered codon bias as a possible candidate for the cause of the low
expression levels. Although the rare codons have a higher effect when clustered at the
start of a gene, the sheer number of rare codons in napA seemed sufficient to interfere
with high expression levels. Site directed mutagenesis to convert the rare codons to
common ones is one method of dealing with the problem. In the case of napA, this
method was problematic, as the rare codons were distributed relatively evenly throughout
the gene. Nevertheless, several mutagenesis attempts were made, the first on one of the
paired rare codons, and the second on the first rare codon, which is the second codon in
the construct.
The site directed mutagenesis reaction generated the correct mutants, based on the
sequencing data. It is interesting to note that the primers used were purified only through
standard desalting, rather than the gel purification called for in the QuickChange
protocol. This substitution did not appear to affect the outcome of the reaction: The total
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transformation efficiency may have been slightly lower, but the mutation was still
successful in the transformants tested.
The construct mutated in at the cluster of rare codons, M1.1, did not show a
visible induction. However, the samples were prepared using TCA precipitation, rather
than heat denaturation. The TCA precipitation did not yield clear gels, which may have
been the reason the induced band was not visible.
Rather than continuing induction experiments with the M1.1 clone, we chose to
use the Rosetta2 pLysS cell strain to address the rare codon problem. Previous studies
have been successful in using the Rosetta strain to express proteins with rare codons
using the T7 expression system (7, 9). Because induction had been observed in the
pLysS strain, we chose to use the Rosetta2 strain containing pLysS.
Two other strategies for raising induction levels were used concurrently with the
Rosetta strain: mutagenesis of the first rare codon and insertion of kanamycin resistance
to produce the construct MK75. Sequencing of the construct indicated that the
mutagenesis was successful, and replica plating ensured that the transposon containing
kanamycin had inserted into ampR on the plasmid. A PCR reaction was also done to
amplify napA to verify that the sequence did not contain a second transposon.
When MK75 was induced in Rosetta2, the induced band appeared more clearly
than in previous experiments. However, when this band was analyzed using MALDIMS, it was identified as β-galactosidase. Because BL21 is wild type for the lac operon, it
was capable of producing β-galactosidase in response to IPTG induction.
This discovery made it clear that the previous conclusions drawn from the
induction experiments were incorrect. There was no evidence that any induction had
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occurred in any cell line with any construct. It was clearly necessary to use a detection
method more sensitive than coomassie gels.
Because the constructs were designed to preserve the reading frame through the
end of the gene to express the his tag and V-5 epitope, it was possible to use the anti-V-5
epitope antibody to detect levels of expression not visible on a gel. The antibody has not
been shown to bind to any bacterial sequences, and the western blots of the napA
inductions verified the specificity of the detection: no cross-linking was observed in
lysates from cells not containing the plasmid, and the western blot from the control
plasmid showed extremely low levels of protein in uninduced fractions.
Blotting experiments of the Rosetta inductions showed very low, non-specific
expression of multiple fragments containing the V5-epitope. A comparison of the BL21
Star (DE3), the pLysS, and the Rosetta strains showed that the BL21 strain had the
highest induction levels, while expression in pLysS was extremely low, Rosetta
expression appeared to be at about the level of the pLysS strain in both the induced and
the uninduced fractions. The lowered induction levels in pLysS expected, as the strain
contains T7lysozyme. The reason for non-specific expression in Rosetta remains a
mystery. The diagram of the pRARE plasmid from Novagen provides little insight, and
more detailed information on the Rosetta strain is considered proprietary by the company.
The presence of multiple bands in the induced fractions suggested that
degradation of the product, rather than inhibition due to codon bias, might be the
problem. This was confirmed through the chloramphenicol pulse-chase experiment:
chloramphenicol inhibits protein synthesis, so that the fate of protein already present in
the cell at the time of chloramphenicol addition can be observed over time. This
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experiment clearly showed that degradation was occurring in the cell, as the protein was
produced. The degradation occurred even when the cells were induced at lower
temperatures. Anaerobic induction yielded a different breakdown pattern, but did not
increase overall expression of the intact protein.
The possibility that addition of molybdenum in the media might decrease
degradation was also considered: in the absence of the intact cofactor, it is possible that
the protein would not fold properly, making it more susceptible to degradation.
However, induction with molybdenum did not make a difference in the degradation
pattern of MK75 expressed in BL21.
To determine whether the presence of the signal sequence affected the
degradation patter, a construct with the original periplasmic signal sequence was created
and used in induction experiments. A single construct, C17, was isolated and shown to
have the insert in the correct orientation. The T7 promoter region and 5’ terminus was
also sequenced, although the rest of the insert was not.
The pilot inductions of C17 showed visible upregulation of a 100kD band, even in
coomassie stained gels. The western blot showed that some degradation was still
occurring, but that the dominant band was at 100kD.
Clearly, the signal sequence allowed the protein to be expressed at a higher level.
One possible reason for this is that most degradation occurs in the cytoplasm of E. coli:
once the protein is in the periplasm, it will not be degraded. Another possibility is that
the signal sequence is necessary for correct protein folding. A recent study by Chan et al
(6) showed that the twin argenine motif in the signal sequence may play a part in the
binding of chaperone proteins in E. coli. If the same is true for S. barnesii’s napA, it
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could explain the increase in expression: if the protein does not fold properly without the
signal sequence, it could be more susceptible to degradation. Both folding and location
may play a part in the increased expression levels.
ProBond Purification
Initial attempts to purify the product were unsuccessful. When using the pLysS
and Rosetta strains, this is not surprising, as there was almost no protein to purify. The
initial purification with C3 induction in BL21 showed no binding to the column.
Lowering the salt concentration in the buffer to 100 mM increased binding of protein.
However, MALDI analysis showed that all the bands visible on the coomassie gel were
contaminants. Based on the western blot analysis, some of the target protein did bind to
the column, though in very small amounts. Most of the protein was still present in the
postcolumn lysate. The dominant band was about 45kD, very close to the 44 kD protein
identified as an elongation factor.
Purification of a C17 induction showed a stronger band a 100kD. This was the
dominant band in the western blot. The gel had a band of similar size, which may be the
target protein. The dominant band on the corresponding gel, however, was still at ~45
kD, which was presumably the elongation factor.
The reason for the low recovery rate is unclear. If the protein is in folded form, it
may be possible that the His tag is not accessible to the column. This possibility can be
tested by running the column under denaturing conditions. If product retention increases,
this is likely the problem.
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Future directions
Although the expression levels using C17 are considerably higher than those
observed in the other construct, expression is still relatively low. It should be possible to
increase expression by altering the induction parameters: a longer induction time at lower
IPTG levels may increase the buildup of protein. Anaerobic expression may also prove
successful.
Insertion of the kanamycin resistance gene into C17 may also be helpful in
boosting expression: ampicillin is a weak antibiotic, and does not persist in the media for
long. This leads to a certain percentage of the cells losing the construct, and lower
overall expression levels.
Expression in a cell line deficient in proteases may prevent some of the
degradation that is still occurring. BL21 is already lon-: removing clp, which encoded
another major protease, would be a possible method for increasing expression levels of
the intact protein.
The purification of the protein also needs to be optimized. The experiments
described here yielded a highly contaminated protein, with relatively low recovery rates
of target protein, based on the western blots. By optimizing the column conditions, it
should be possible to increase the purity and yield of the sample. If induction levels
remain low, it may be necessary to perform a pre-column purification step, such as
ammonium sulfate precipitation. If the his tag is inaccessible due to protein folding, it
may not be possible to purify the product in native form using the ProBond purification
system. In this case, other protein purification techniques would have to be used.
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The activity of the expressed protein must also be determined. Initial activity
assays on the lysate and purified fractions of C17 were unsuccessful: however, as no
positive control was performed, the results are inconclusive.
The system for site-directed mutagenesis has been developed: once the expression
and purification of the product has been optimized, mutants can be generated
QuickChange kit, and the active site can be probed.
Conclusions
The genetic portion of the project was a success. The entire napA gene from
Sulfurospirillum barnesii was cloned into the pET101 expression vector, and verified
through sequencing. Sequencing primers were designed for all but a small portion of the
construct. Site directed mutagenesis was successfully performed on the construct,
demonstrating that the QuikChange system can be used to alter specific bases in the
construct.
Expression of the cloned product was only partially successful. Protein was
expressed and partially purified: however, expression levels were low, and purification
was incomplete with a low recovery rate and high contamination. The activity of the
expressed protein was also not verified. These issues must be addressed before the
system can be used to probe the active site using site directed mutagenesis.
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Appendix 1
Organisms with a NapA homologue. The list was compiled from the NCBI database
using the tblastn search tool. The search was performed on May 27, 2007.
Bacteria
alphaproteobacteria
•
Caulobacterales
o Caulobacteraceae
 Caulobacter crescentus
•
Rhizobiales
o Bradyrhizobiaceae
 Bradyrhizobium sp. BTAi1
 Bradyrhizobium sp. ORS278
 Bradyrhizobium japonicum
 Rhodopseudomonas Sp.
o Rhizobiaceae
 Agrobacterium tumefaciens
 Sinorhizobium meliloti
o Phyllobacteriaceae
 Mesorhizobium loti
•
Rhodobacterales
o Rhodobacteraceae
 Rhodobacter capsulatus
 Rhodobacter sphaeroides
 Roseobacter denitrificans
 Paracoccus denitrificans
•
Rhodospirillales
o Rhodospirillaceae
 Magnetospirillum magneticum
 Magnetospirillum magnetotacticum
β-proteobacteria
•
Burkholderiales
o Alcaligenaceae
 Bordetella bronchiseptica
 Bordetella parapertussis
o Burkholderiaceae
 Burkholderia cenocepacia
 Burkholderia cepacia
 Burkholderia mallei
 Burkholderia pseudomallei
 Burkholderia thailandensis
 Burkholderia vietnamiensis
 Burkholderia xenovorans
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•
•

 Cupriavidus necator (Ralstonia eutropha)
 Cupriavidus metallidurans (Ralstonia metallidurans)
Methylophilales
o Methylophilaceae
 Methylobacillus flagellatus
Rhodocyclales
o Rhodocyclaceae
 Azoarcus sp. BH72
 Dechloromonas aromatica

γ-proteobacteria
•
Aeromonadales
o Aeromonadaceae
 Aeromonas hydrophila subsp. hydrophila
 Aeromonas salmonicida subsp. Salmonicida
•
Alteromonadales
o Alteromonadaceae
 Saccharophagus degradans
o Colwelliaceae
 Colwellia psychrerythraea
o Psychromonadaceae
 Psychromonas ingrahamii
o Shewanellaceae
 Shewanella amazonensis
 Shewanella sp. ANA-3
 Shewanella baltica
 Shewanella denitrificans
 Shewanella frigidimarina
 Shewanella loihica
 Shewanella oneidensis
 Shewanella putrefaciens
•
Enterobacteriales
o Enterobacteriaceae
 Erwinia carotovora
 Escherichia coli
 Salmonella enterica
 Salmonella typhimurium
 Shigella boydii
 Shigella dysenteriae
 Shigella flexneri
 Shigella sonnei
 Yersinia enterocolitica
 Yersinia pseudotuberculosis
 Yersinia pestis
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•
•

•

•
•

Oceanospirillales
o Hahellaceae
 Hahella chejuensis
Pasteurellales
o Pasteurellaceae
 Actinobacillus pleuropneumoniae
 Aggregatibacter actinomycetemcomitans
 Haemophilus ducreyi
 Haemophilus influenzae
 Haemophilus somnus
 Mannheimia succiniciproducens
 Pasteurella multocida
Pseudomonadales
o Moraxellaceae
 Acinetobacter sp. YY-5
o Pseudomonadaceae
 Pseudomonas aeruginosa
 Pseudomonas mendocina
 Pseudomonas stutzeri
Thiotrichales
o Piscirickettsiaceae
 Thiomicrospira crunogena
Vibrionales
o Vibrionaceae
 Photobacterium profundum
 Vibrio cholerae
 Vibrio fischeri
 Vibrio parahaemolyticus
 Vibrio vulnificus

δ-proteobacteria
•
Desulfovibrionales
o Desulfovibrionaceae
 Desulfovibrio desulfuricans
•
Myxococcales
o Myxococcaceae
 Anaeromyxobacter dehalogenans
ε-proteobacteria
•
Campylobacterales
o Campylobacteraceae
 Arcobacter butzlerii
 Campylobacter coli
 Campylobacter curvus
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 Campylobacter concisus
 Campylobacter fetus subsp. Fetus
 Campylobacter lari
 Campylobacter jejuni subsp. Jejuni
 Campylobacter upsaliensis
 Sulfurospirillum barnesii SES-3
o Helicobacteraceae
 Helicobacter hepaticus
 Thiomicrospira denitrificans
 Wolinella succinogenes
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Appendix 2
A. Ses-3 DNA purification
Lysis buffer pH 7.5
50 mM EDTA
0.1 M NaCl
Tris-buffered phenol
Mix equal amounts of Tris (1M, desired pH) and phenol. Mix, and let stand until layers
are separated. Discard the upper (aqueous) layer. Repeat twice more, and store under
Tris buffer.
B. Agarose gels
TAE stock (50X) 500 ml
121 g Tris
28.55 ml Glacial Acetic Acid
9.3 g EDTA (disodium salt)
to 500 ml with di H2O
To pour gel: 0.8 g agarose/100 ml TAE stock. Weigh flask, microwave until agarose is
melted. Bring back up to original weight with di water, let cool to ~45oC. If required,
add 2 µl ethidium bromide stock solution (10 mg/ml) (if running small products, do not
add ethidium bromide: stain gel in ethidium bromide solution after running). Swirl to
mix, and pour into mold. Let solidify at least 40 min. Run in 1 x TAE buffer.
C. media
LB liquid broth, 1 L
800 mls nanopure water
10 g tryptone (1%)
5 g yeast extract (0.5%)
10 g NaCl (1%)
Mix, and adjust to pH 7. Bring to 1 L with nanopure water, and autoclave.
LB Agarose plates
Add 15 g agar to 1 L LB broth. Autoclave. Pour when cooled to ~45oC.
Selective media
Add appropriate antibiotic after autoclaving. For plates, add just before pouring.
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Antibiotic
Ampicillin (amp)
Kanamycin (kan)
Carbenicillin (cam)
Tetracycline (tet)

Stock
50 mg/ml
10 mg/ml
25 mg/ml
25 mg/ml

Final conc.
100 µg/ml
20 µg/ml
25 µg/ml
24 µg/ml

Dissolved in
Ethanol
di water
Ethanol
Ethanol

Volume in media
2 µl/ml
2 µl/ml
1 µl/ml
1 µl/ml

Anaerobic media
Prepare LB broth as described above, and aliquot into anaerobic bottles. For pilot
inductions, use small bottles and 10 ml media: for larger inductions use 25 or 50 ml.
Degas with N2 ~10 minutes, insert blue cap and crimp top, Degas head space for 5 min.
autoclave.
Stocks of lactate, DMSO, and sodium molybdate:
Lactate, 2 M:
DMSO, 1.4 M:
Sodium molybdate, 100 µM:
Filter sterilize, and add 10 µl/ml to anaerobic media
D. Protein minigels
Running buffer, 1x, 1 L:
800 ml diH2O
4.5 g Tris
1 g sodium dodecyl sulfate (lauryl sulfate)
21.25 g glycine.
Bring final volume to 1L
Sample buffer
950 µl Laemmli sample buffer
50 µl Beta-mercaptoehtanol
Coomassie Stain
150 ml diH2O
0.12 g Coomassie Brilliant Blue
125 ml Methanol
50 ml Glacial Acetic Acid
Up to 500 ml diH2O
E. Western blot
Transfer buffer
700 mls di H2O
14.4 g glycine
3.03 g Tris
100 ml methanol
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Bring to 1 L with di H2O pH should be 8.3: usually does not need adjusting
Phosphate buffered saline
1800 mls di H2O
16 g sodium chloride
0.4 g sodium phosphate (dibasic)
2.3 g potassium phosphate (monobasic)
0.2 g calcium chloride CaCl2·2H2O
0.3 g magnesium chloride MgCl·6H2O
Adjust pH to 7.4. Bring to 2 L with di H2O
Killer filler, 2 L
Solution A:
10 g casein
200 ml 0.1 M sodium hydroxide (1N=1M)
Solution B:
1800 ml PBS
10 g BSA
Mix solutions A and B and adjust pH to 7.4. Add:
0.2 g phenol red
3.6 g sodium azide
Carbonate buffer, pH 9.8
800 mls H2O
8.4 g sodium bicarbonate
0.2 g magnesium chloride
Adjust pH to 9.8
Bring to final volume of 1 L
Tris-buffered saline (TBS)
9 g NaCl
6.05 g Tris
Final volume 1 L with H2O.
Adjust pH to 7.5
Tween Tris-buffered saline (TTBS)
1 L TBS
0.5 ml Tween-20
Adjust pH to 7.5
Developing solution
Solution A:
0.0075 g 5-Bromo-4-chloro-3-indolyl phosphate (BCIP)
0.5 ml N,N-dimethyl formamide

90

Solution B:
0.015 g Nitro blue tetrazolim (nitro-BT)
0.35 ml N,N-dimethyl formamide
0.15 ml diH2O
Make solutions A and B in separate microfuge tubes. Combine solutions A and B in 50
ml carbonate buffer. Do not store.

λ phage transduction
TBMM broth, 1L
800 ml nanopure water
10 g tryptone
5 g NaCl
Bring volume to 1 L, autoclave, then add:
0.2% maltose (2 g/L) from filtered stock
10 mM MgSO4 (2.47 g/L) from filtered stock
1g/L thiamine from filtered stock
TB1 plates, 500 ml
400 ml nanopure water
5 g tryptone
2.5 g NaCl
5.5 g Difco agar
Bring to 500 L with nanopure water
Autovclave, and pour plates when cooled to ~45oC
Top agar, 500 ml
400 ml nanopure water
5 g tryptone
2.5 g NaCl
3.5 g agar
TMG buffer, 100 ml
80 ml nanopure water
0.12 g Tris base
0.246 g MgSO4·7H2O
Bring final volume to 100 ml, autoclave
ProBond column purification
Native purification buffer 5x, 400 ml
350 mls diH2O
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14 g NaH2PO (250 mM )
g NaCl (500 mM)
Adjust pH to 8.0. Bring final volume to 400 ml. Store at room temperature
To make 1x solution, dilute 1:5, and adjust pH to 8.0.
Imidazole solutions
Buffer stock solution A (10x) 100 ml
80 ml diH2O
2.76 g NaH2PO4 (200 mM)
29.29 g NaCl (2.5 M)
Bring to final volume of 100 ml with di H2O
Buffer stock solution B
80 ml diH2O
2.84 g Na2HPO4 (200 mM)
29.29 g NaCl (2.5 M)
Imidazole Stock Solution
50 ml diH2O
20.6 g imidazole (3 M)
8.77 ml stock solution A
1.23 ml stock solution B
Adjust pH to 6.0. Bring final volume to 100 ml.
Native wash buffer, 50 ml
50 ml 1x native purification buffer
335 µl imidazole stock solution (20 mM final conc.)
Adjust pH to 8.0.
Native elution buffer, 30 ml
27.5 ml native purification buffer
2.5 ml imidazole stock solution (250 mM final conc.)
Adjust pH to 8.0
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Appendix 3
napA primers used for amplification and sequencing. Primers in red are exact matches,
primers in blue are mutagenesis primers. The brackets denote the signal sequence, which
was removed in the construction of C42 and C3.
SeNapAF200.3
CCAC>>>>>>>>>>>>>>>>>>>>>
[1 ATGTCGCTTTCAAGAAGAGACTTTCTAAAAACAACTGCCGCTGCTAGTGCTGCGGCTGCGGTGGGTATTGGTGTACCCGC
SeNapAF200.2
CACCATG>>>>>>>>>>>>>>>>>
81 TGAGCTT]AAGGCTGCTGGTGAGCAAGCGGAAGCTAATTGGAAATGGGATAAGGCTGTTTGCCGTTTCTGTGGTACCGGTT
…CCTTCACCATG>>A>>>>>>>>>>>
SeNapmutF3&R3
161 GTGGTATTATGGTGGCGACCAAAGAGGGTAAAATTGTCGCTGTCAAAGGTGATCCAGCCGCTCCCGTCAATCGTGGACTT

241 AACTGTATCAAAGGCTATTTTAACGCCAAAATTATGTACGGTGCGGACAGATTAAAACAACCCCTTCTTCGTATGAACGA

321 TAAAGGTGAGTTTGACAAAAAAGGTCAGTTTAAACCTGTTTCATGGAAGCGTGCGTTTGATGAGATGGAAAAACACATCA
SeNapAF202
>>>>>>>>>>>
401 AAGCAGCACTTAAAGTGGGTGGGCCAGAGGCGATTGGTGTGTTTGGTTCAGGTCAGTACACCATTCAAGAAGGGTATGCG
SeNapAR201
>>>>>>>>><<<<<<<<<<<<<<<<<<<<
481 GCTGCTAAGATGATGAAGGCTGGTTTTCGTGCCAACGGAATTGATCCTAATGCACGTCACTGTATGGCTTCAGCGGTTGC
SeNapAF203
>>>>>>>>>>>>>>>>>>>
561 AGGCTTTATGCAAACCTTTGGTATTGATGAGCCAGCAGGGTGTTATGATGATATTGAAATTACCGATACTATCATTACAT

641 GGGGCGCTAATATGGCAGAGATGCACCCGATTTTATGGTCACGTGTGAGTGATAGAAAACTTACCTCACCTGATCGTGTC
SeNapAF204
>>>>>>>>>>>>>>>>>>>>>>
721 AAAATCGTTAACCTCTCAACCTATACCCACCGCTGTTCTGACCTTGCGGACCTTGAAATCATCTTCTCTCCAAGTACCGA

801 TTTGGCAATTTGGAACTATATCGCTCGTGAGATTGTCTACAATCATCCAGAAGCGATTGATTGGGATTTTGTTAAGAAAA
SeNapAF205
>>>>>>>>>>>>>>>>>>
881 ATACCATTTTTACAACAGGTTTTGCGAACATTGGTTATGGTATGCGAACCGAGGCTGAGGCTAAAAAATTAGGCTATTCT

961 GCAAAAGAACTTGAAGTCATTAAAAAAGAAGATGCCAAAGTCATTTCTGAAAAAGAAGCTCCAGGTCTTGCACACTTAGG

1041 TGTCAAAGCAGGCGATGTTATGAAAATGGACAAAGCAGATGCAGCTGGTGCACATTGGGAAATTAGCTTTGAAGATTTCA

1121 AAAAAGCTTTAGAGCCTTATACGCTGGAGTATGTCGCAAAGATTTCTAAAGGTAATCCCGATGAAAAACTAGAAGATTTC

1201 AAAGTTAAACTTCAAGAACTTGCCAATCTTTATATTGAAAAAAATAGAAAAGTCGTTAGTTTCTGGACAATGGGCTTTAA

1281 CCAGCACCAAAGAGGCACATGGGTTAATGAGCAGTCCTACATGGTTCACTTCCTTTTAGGCAAACAAGCCAAACCAGGTG
CjNapF1
SeNapAR206
>>>>>>>>>>>>>>>>>>>>>
<<<<<<<<<<<<<<<<<<<<<<
1361 ATGGAGCGTTTTCTCTTACAGGACAGCCAAGTGCCTGTGGAACTGCACGTGAAGTAGGTACCTTTACACACCGACTCCCC

1441 NCAGATATGGATGTTTCCATTCCCAAACATAGAGAAGTGAGTGAAAAAATTTGGAAGCTACCTGCTGGCACACTCAACCC

93

1521 AATGGGTTACCAACACATTATGAACATNCACCGTCAAATTGAGAGTGGAAAAATCAAATTTGCATGGGTAAACGTCTGTA
SeNapAF207
>>>>>>>>>>>>>>>>>>
1601 ATCCTTACCAAGATACTGCCAATGCCAATCACTGGATTAAAGCAGCACGAGAGCTCGATAACTTTATTGTTTGTTCCGAT
>>>>>
1681 GCGTATCCTGGGATTTCTGCCAAAGTATCTGACCTTATTCTTCCCTCAGCAATGATTTATGAAAAATGGGGCTCTTACGG
SeNapmutF1&F2
SeNapAF208
>>>>>>>>>>>>>C>C>>>>>>>>>>>>>>>>>>
>>>>>>>>>
1761 TAATGCCGAGCGAAGAACACAACACTGGAGACAGCAAGTCTTACCTGTTGGCGATGCGATGAGCGATACATGGCAGTGGG
>>>>>>>>>
1841 TTGAACTTTCAAAACGCTTTACGATTAAAGACGTGTGGGGTGAGCAACCGATTAAAGGTGGCAAGTTACCAAACGTCATT

1921 GAAGCGGCAAAAGCAATGGGCTACAAAGAGACTGACACCATGTATGATGTTCTTTTTGCCACACCATTTGCAAAACAATT
SeNapAF209
>>>>>>>>>>>>>>>>>>>
2001 TAAAGCAGATGATGCCATTGGTAAAGGGTTCGATAACAGTGAAGTCTTTGGTGATGCTCGAAAAGTCATGGGCAGTGATG

2081 GCAAAGAGTGGACGGGTTATGGCTTCTTTATTCAAAAATCGATTTGGGAAGAGTACCGTCAGTTTGGATTAGGACATGGA
SeNapAF210
>>>>>>>>>>>>>>>
2161 CATGACCTTGCAGACTTTGATACGTATCATAAAGTAAGAGGTTTAAAATGGCCTGTTGTGGATGGTAAAGAGACCCAATG
>>>
2241 GCGTTTTAATGCAAAATACGACCCGTATGCTGCAAAAGCAGGCAATGGTGATTTTGCTTTCTATGGTGATTTTGCAAAAG

2321 CCCTTAAAAAAGGTAACTTAGTAAAACCAACCACAGAAGAGACTTATTCACTTAAAAATAAAGCAAAAATCTTCTTTAGA
SeNapAF211
>>>>>>>>>>>>>>>>>>
2401 CCGTACATGGATCCATGTGAAATGCCAGATCGTGAGTACGATACATGGCTATGTACAGGACGTGTGTTAGAGCACTGGCA
>>>
2481 TAGTGGTACGATGACCATGAGGGTACCTGAACTTTACCGTGCCGTTCCTGAAGCGCTTTGCTACATGCACCCAGAAGATG

2561 CAAAAGCAAAAGGGTTTAAACAAGGCGATATGATTTGGTTAGAGAGTCGTCGAGGTTCATGTAAAGCCCGTGTTGAAACC
SeNapAR11
<<<<<<<<<<<<<<<<<<<<<
2641 AGAGGACGTAATAGAACGCCTCGTGGATTGGTGTTTGTTCCATGGTTTGATGAGAAGGTTATGATTAATAAAGTCTGCCT
SeNapAR200.1
<<<<<<<<<<<<<<<<<<<<<<
2721 TGATGCAACGTGCCCGATTTCAAAACAGACCGATTATAAAAAATGTGCTGTTAAGCTCTATAAAGCCTAA
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Appendix 4
Open reading frame translation of combined sequences from C3, C42, and C17.
1 atgtcgctttcaagaagagactttctaaaaacaactgccgctgct
M S L S R R D F L K T T A A A
46 agtgctgcggctgcggtgggtattggtgtacccgctgagcttaag
S A A A A V G I G V P A E L K
91 gctgctggtgagcaagcggaagctaattggcgatgggacaaggct
A A G E Q A E A N W R W D K A
136 gtgtgccgtttctgtggtaccggttgtggtattatggtggcgacc
V C R F C G T G C G I M V A T
181 aaagagggtaaaattgtcgctgtcaaaggtgatccagccgctccc
K E G K I V A V K G D P A A P
226 gtcaatcgtggacttaactgtatcaaaggctattttaacgccaaa
V N R G L N C I K G Y F N A K
271 attatgtacggtgcggacagattaaaacaaccccttcttcgtatg
I M Y G A D R L K Q P L L R M
316 aacgataaaggtgagtttgacaaaaaaggtcagtttaaacctgtt
N D K G E F D K K G Q F K P V
361 tcatggaagcgtgcgtttgatgagatggaaaaacacatcaaagca
S W K R A F D E M E K H I K A
406 gcacttaaagtgggtgggccagaggcgattggtgtgtttggttca
A L K V G G P E A I G V F G S
451 ggtcagtacaccattcaagaagggtatgcggctgctaagatgatg
G Q Y T I Q E G Y A A A K M M
496 aaggctggttttcgtgccaacggaattgatcctaatgcacgtcac
K A G F R A N G I D P N A R H
541 tgtatggcttcagcggttgcaggctttatgcaaacctttggtatt
C M A S A V A G F M Q T F G I
586 gatgagccagcagggtgttatgatgatattgaaattaccgatact
D E P A G C Y D D I E I T D T
631 atcattacatggggcgctaatatggcagagatgcacccgatttta
I I T W G A N M A E M H P I L
676 tggtcacgtgtgagtgatagaaaacttacctcacctgatcgtgtc
W S R V S D R K L T S P D R V
721 aaaatcgttaacctctcaacctatacccaccgctgttctgacctt
K I V N L S T Y T H R C S D L
766 gcggaccttgaaatcatcttctctccaagtaccgatttggcaatt
A D L E I I F S P S T D L A I
811 tggaactatatcgctcgtgagattgtctacaatcatccagaagcg
W N Y I A R E I V Y N H P E A
856 attgattgggattttgttaagaaaaataccatttttacaacaggt
I D W D F V K K N T I F T T G
901 tttgcgaacattggttatggtatgcgaaccgaggctgaggctaaa
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946
991
1036
1081
1126
1171
1216
1261
1306
1351
1396
1441
1486
1531
1576
1621
1666
1711
1756
1801
1846
1891

F A N I G Y G M R T E A E A K
aaattaggctattctgcaaaagaacttgaagtcattaaaaaagaa
K L G Y S A K E L E V I K K E
gatgccaaagtcatttctgaaaaagaagctccaggtcttgcacac
D A K V I S E K E A P G L A H
ttaggtgtcaaagcaggcgatgttatgaaaatggacaaagcagat
L G V K A G D V M K M D K A D
gcagctggtgcacattgggaaattagctttgaagatttcaaaaaa
A A G A H W E I S F E D F K K
gctttagagccttatacgctggagtatgtcgcaaagatttctaaa
A L E P Y T L E Y V A K I S K
ggtaatcccgatgaaaaactagaagatttcaaagttaaacttcaa
G N P D E K L E D F K V K L Q
gaacttgccaatctttatattgaaaaaaatagaaaagtcgttagt
E L A N L Y I E K N R K V V S
ttctggacaatgggctttaaccagcaccaaagaggcacatgggtt
F W T M G F N Q H Q R G T W V
aatgagcagtcctacatggttcacttccttttaggcaaacaagcc
N E Q S Y M V H F L L G K Q A
aaaccaggtgatggagcgttttctcttacaggacagccaagtgcc
K P G D G A F S L T G Q P S A
tgtggaactgcacgtgaagtaggtacctttacacaccgactcccc
C G T A R E V G T F T H R L P
gcagatatggatgtttccattcccaaacatagagaagtgagtgaa
A D M D V S I P K H R E V S E
aaaatttggaagctacctgctggcacactcaacccaatgggttac
K I W K L P A G T L N P M G Y
caacacattatgaacattcaccgtcaaattgagagtggaaaaatc
Q H I M N I H R Q I E S G K I
aaatttgcatgggtaaacgtctgtaatccttaccaagatactgcc
K F A W V N V C N P Y Q D T A
aatgccaatcactggattaaagcagcacgagagctcgataacttt
N A N H W I K A A R E L D N F
attgtttgttccgatgcgtatcctgggatttctgccaaagtatct
I V C S D A Y P G I S A K V S
gaccttattcttccctcagcaatgatttatgaaaaatggggctct
D L I L P S A M I Y E K W G S
tacggtaatgccgagcgaagaacacaacactggagacagcaagtc
Y G N A E R R T Q H W R Q Q V
ttacctgttggcgatgcgatgagcgatacatggcagtgggttgaa
L P V G D A M S D T W Q W V E
ctttcaaaacgctttacgattaaagacgtgtggggtgagcaaccg
L S K R F T I K D V W G E Q P
attaaaggtggcaagttaccaaacgtcattgaagcggcaaaagca
I K G G K L P N V I E A A K A
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1936 atgggctacaaagagactgacaccatgtatgatgttctttttgcc
M G Y K E T D T M Y D V L F A
1981 acaccatttgcaaaacaatttaaagcagatgatgccattggtaaa
T P F A K Q F K A D D A I G K
2026 gggttcgataacagtgaagtctttggtgatgctcgaaaagtcatg
G F D N S E V F G D A R K V M
2071 ggcagtgatggcaaagagtggacgggttatggcttctttattcaa
G S D G K E W T G Y G F F I Q
2116 aaatcgatttgggaagagtaccgtcagtttggattaggacatgga
K S I W E E Y R Q F G L G H G
2161 catgaccttgcagactttgatacgtatcataaagtaagaggttta
H D L A D F D T Y H K V R G L
2206 aaatggcctgttgtggatggtaaagagacccaatggcgttttaat
K W P V V D G K E T Q W R F N
2251 gcaaaatacgacccgtatgctgcaaaagcaggcaatggtgatttt
A K Y D P Y A A K A G N G D F
2296 gctttctatggtgattttgcaaaagcccttaaaaaaggtaactta
A F Y G D F A K A L K K G N L
2341 gtaaaaccaaccacagaagagacttattcacttaaaaataaagca
V K P T T E E T Y S L K N K A
2386 aaaatcttctttagaccgtacatggatccatgtgaaatgccagat
K I F F R P Y M D P C E M P D
2431 cgtgagtacgatacatggctatgtacaggacgtgtgttagagcac
R E Y D T W L C T G R V L E H
2476 tggcatagtggtacgatgaccatgagggtacctgaactttaccgt
W H S G T M T M R V P E L Y R
2521 gccgttcctgaagcgctttgctacatgcacccagaagatgcaaaa
A V P E A L C Y M H P E D A K
2566 gcaaaagggtttaaacaaggcgatatgatttggttagagagtcgt
A K G F K Q G D M I W L E S R
2611 cgaggttcatgtaaagcccgtgttgaaaccagaggacgtaataga
R G S C K A R V E T R G R N R
2656 acgcctcgtggattggtgtttgttccatggtttgatgagaaggtt
T P R G L V F V P W F D E K V
2701 atgattaataaagtctgccttgatgcaacgtgcccgatttcaaaa
M I N K V C L D A T C P I S K
2746 cagaccgattataaaaaatgtgctgttaagctctataaagcctaa 2790
Q T D Y K K C A V K L Y K A *
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Appendix 5: table of vectors, constructs, and cell lines
Table 2: Vectors and bacterial host strains used. Parenthesis indicate official
designation.

Vectors:

Characteristics:

Source:

pET101/D/TOPO

T7 promoter, cloning site

Invitrogen

C42 (PLB1)

napA -signal sequence

pET101

C3 (PLB2)

napA -signal sequence

pET101

MK75 (PLB1.1)

C42; kanR, first rare codon mutatation

C42

M1.1 (PLB1.3)

C42 codon at 1687 mutated

C17

napA +signal sequence

pET101

Host Strains:

Genotype:

Source:

BL21Star(DE3)

F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3)

Invitrogen

BL21Star(DE3) pLysS

F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3)

Invitrogen

(PLB4)

pLysS
Rosetta2 pLysS

F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3)

Novagen

pLysS pRare
Top10

F-mcrA∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15

Invitrogen

∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU
galK rpsL (StrR) endA1 nupG
LE392

λNK1105 permissive

Trun Lab

Phage:

Genotype:

Source:

λNK1105

λcI857 b522 Pam80 ∆kan ptac-rtnpase

Trun lab
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